CN112852873A - Construction method of porcine delta coronavirus infectious clone plasmid - Google Patents
Construction method of porcine delta coronavirus infectious clone plasmid Download PDFInfo
- Publication number
- CN112852873A CN112852873A CN202110154305.8A CN202110154305A CN112852873A CN 112852873 A CN112852873 A CN 112852873A CN 202110154305 A CN202110154305 A CN 202110154305A CN 112852873 A CN112852873 A CN 112852873A
- Authority
- CN
- China
- Prior art keywords
- seq
- pdcov
- gene
- sequence
- chn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20051—Methods of production or purification of viral material
- C12N2770/20052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/20—Pseudochromosomes, minichrosomosomes
- C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a construction method of porcine delta coronavirus infectious clone plasmid, belonging to the field of animal infectious disease control and biotechnology. The invention is based on a BAC system and a homologous recombination one-step cloning method to save a reverse genetic system of a PDCoV CHN-HN-2014 strain recombinant virus, 5 gene segments of a strain are cloned into an intermediate vector pBAC-M-PDCoV in one step to obtain a recombinant plasmid pBAC-CHN-HN-2014 containing the PDCoV CHN-HN-2014 strain full-length cDNA, and the recombinant virus rCHN-HN-2014 is saved after cells are transfected, thereby establishing a porcine delta coronavirus reverse genetic operation platform and laying a foundation for deeply researching the infection and pathogenic mechanism of the PDCoV. Meanwhile, aiming at the actual problem that no available PDCoV vaccine exists in China at present, the PDCoV infectious clone platform can be used for developing a safer and more efficient novel PDCoV genetic engineering vaccine, and can also be used as a live virus vector for developing a multi-connected vaccine, so that the PDCoV infectious clone platform has great value for the research related to the virus.
Description
Technical Field
The invention belongs to the field of animal infectious disease control and biology. In particular to a construction method of porcine delta coronavirus infectious clone plasmid.
Background
Porcine delta coronavirus (PDCoV) belongs to the family of coronaviridae, belongs to the genus of delta coronavirus, has a cyst membrane, has single-stranded positive-strand RNA as a genome, and is the only delta coronavirus which is successfully separated at present. The porcine delta coronavirus was first discovered by Woo et al when samples collected from different animals in 2010-2011 in hong Kong area, China (Woo P.C.Y., Discovery of seven novel mammalia and alias coronaviruses in the gene deltacoronaviruses subports of genes as the gene source of alphacoronaviruses and aconaviruses and alias as the gene source of gamma-oronaviruses and deltacoronaviruses. J.Virol.2012,86: 95-4008). PDCoV infection first breaks out in the United states in early 2014 and quickly reaches a plurality of states in the United states, and then countries such as Korea, Canada, China, Thailand, Vietnam, Laos, Japan also successively report that PDCoV is detected (Wang L et al, Port coronavirus HKU15 detected in 9US states,2014, Emerg Infect Dis 2014,20(9): 1594-. Until now, a plurality of topic components are separated to PDCoV at home and abroad, animal experiments prove that the PDCoV has stronger pathogenicity to piglets, can cause the piglets to have typical intestinal disease symptoms such as vomit, diarrhea and the like, and the cesarean examination shows that the intestinal wall of the infected piglets becomes thin and transparent, and cecum and colon are dilated and accompanied by a large amount of yellow liquid; histopathological analysis found severe atrophy of the villi of the duodenum, jejunum, ileum (Ma Y M et al, Origin, evolution, and vision of soil deltacononavirus in the United states. MBIO 2015,6(2): e 00064; Dong et al, Isolation, genetic characterization, and pathology of a Chinese soil deltacononavirus strain CHN-HN-2014.Vet Microbiol.2016,196: 98-106). Although the mortality rate caused by the PDCoV infection is lower compared with the Porcine Epidemic Diarrhea Virus (PEDV) and the transmissible gastroenteritis virus (TGEV), the PDCoV infection and the PEDV and the TGEV have mixed infection phenomena, thereby causing more serious clinical symptoms and threatening the healthy development of the pig industry. As a newly discovered porcine enterocoronavirus in recent years, the number of PDCoV strains passaged in vitro is still small relative to PEDV, the mechanism of PDCoV infection and pathogenicity is not completely understood, and no available vaccine or specific antiviral drug exists, so that the method has important value in further increasing epidemiological investigation, separating clinical strains and researching pathogenic mechanisms.
The reverse genetic operation system of the virus can realize virus modification by modifying a target gene, including mutation, deletion or insertion of foreign genes and other operations, research the function of virus coding protein, determine virulence genes and provide a technical platform for research and development of novel vaccines and live virus vector vaccines. The current methods for constructing reverse genetic operation systems of positive-strand RNA viruses mainly comprise 4 methods: 1) constructing a reverse genetic operation system of the virus by a targeted RNA recombination technology; 2) using a Bacterial Artificial Chromosome (BAC) system; 3) constructing a reverse genetic operation system of the virus by using an in vitro cDNA connection method; 4) infectious clones of the virus were constructed using vaccinia virus as a vector (Almaz n F, Coronavir reverse genetic systems: infectious clones and replication. Virus Res.2014,189: 262-; masters PS, Coronavir reverse genetics by targeted RNA recombination. curr Top Microbiol Immunol.2005,287: 133-. However, the construction of PDCoV infectious clone mainly adopts an in vitro cDNA connection method, which connects a plurality of cDNA fragments of virus by using type II restriction enzyme, obtains full-length RNA by using T7 RNA polymerase in vitro transcription, and electrically transfers the full-length RNA to a sensitive cell line to save recombinant virus. The method for rescuing the virus generally needs to simultaneously electrically transfer the N gene transcript of the corresponding virus so as to improve the rescuing efficiency, and meanwhile, T7 RNA polymerase can generate mutation during working, which influences the rescuing efficiency of the method to a certain extent. The BAC system does not involve in vitro connection and transcription, the rescue efficiency of the recombinant virus is high, and the mature CRISPR/Cas9 technology is added, so that the recombinant plasmid can be efficiently reconstructed, and the system has stronger advantages. In addition, the existing reverse genetic operation system constructed based on the BAC system mostly adopts a multi-step homologous recombination method for construction strategies, and the period is relatively long. Based on the defects and shortcomings of the construction of the PDCoV reverse genetic operation system, a BAC system and a homologous recombination one-step cloning method are adopted to quickly construct PDCoV infectious clone plasmids, transfect susceptible cells to save recombinant viruses, and establish a good foundation for the subsequent research of PDCoV.
Disclosure of Invention
The invention mainly aims to provide a construction method of porcine delta coronavirus infectious clone plasmids. The invention aims at porcine delta coronavirus CHN-HN-2014 strain (GenBank accession number: KT336560) (Dong N, Fan L, Yang H, Liu H, Du T, Fan P, Wang D, Chen H, Xiao S.isolation, genomic characterization, and pathogenesis of a porcine gene of porcine gene transcriptional and transcriptional mutant strain CHN-HN-2014.Vet Microbiol.2016,196:98-106), and BAC system and homologous recombination one-step cloning method are adopted to obtain porcine delta coronavirus CHN-HN-2014 strain infectious clone plasmid pBAC-CHN-HN-PDC and recombinant virus rCHN-HN-2014, thereby providing a very valuable technical platform for the subsequent research of the oV.
The technical scheme of the invention is as follows:
a method for constructing infectious clone plasmids of porcine delta coronavirus comprises the following steps:
(1) extracting RNA of the porcine delta coronavirus and performing reverse transcription to obtain cDNA;
(2) using the cDNA as a template, designing primers to carry out PCR amplification respectively to obtain a 5 'end gene sequence, a 3' end gene sequence and 5 gene fragments of the porcine delta coronavirus, wherein the 5 gene fragments contain a homologous sequence of 20bp, and in addition, a 15121 site C silencing mutation is changed into A, so that a ClaI endonuclease sequence is eliminated and is used as a genetic marker;
(3) taking pBAC-AJ1102 plasmid as a template, designing primers, and respectively carrying out PCR amplification to obtain a CMV promoter and an HDV-BGH gene sequence;
(4) cloning a CMV promoter, a 5 'end gene sequence, a 3' end gene sequence, a poly (A) structure of 27 adenine deoxynucleotides (A), a hepatitis C virus (HDV) ribozyme self-cleavage site and a bovine growth hormone termination sequence (BGH) into a low-copy vector pBeloBAC11 by using an ApaLI and HindIII restriction endonuclease and a multi-step fusion PCR method by using a BAC system to obtain an intermediate vector pBAC-M-PDCoV;
(5) 5 gene segments are subjected to homologous recombination in proportion and are cloned into an intermediate vector pBAC-M-PDCoV in one step to obtain a recombinant plasmid pBAC-CHN-HN-2014;
(6) transforming the recombinant product into DH10B chemically competent cells, screening positive clones by PCR, carrying out amplification culture on positive clones with correct sequencing, and extracting plasmids.
The 5 'end gene sequence, the 3' end gene sequence and the sequences of the 5 gene segments are respectively as follows:
5' end gene sequence: as shown in SEQ ID NO. 1;
3' end gene sequence: as shown in SEQ ID NO. 2;
gene fragment A: as shown in SEQ ID NO. 3;
gene fragment B: as shown in SEQ ID NO. 4;
gene fragment C: as shown in SEQ ID NO. 5;
gene fragment D: as shown in SEQ ID NO. 6;
gene fragment E: shown as SEQ ID NO. 7.
The primers for PCR amplification of 5 'end gene sequence, 3' end gene sequence and 5 gene segments are respectively as follows:
PDCoV-5’-F:SEQ ID NO:11
PDCoV-5’-R:SEQ ID NO:12
PDCoV-3’-F:SEQ ID NO:13
PDCoV-3’-R:SEQ ID NO:14
A-F:SEQ ID NO:15
A-R:SEQ ID NO:16
B-F:SEQ ID NO:17
B-R:SEQ ID NO:18
C-F:SEQ ID NO:19
C-R:SEQ ID NO:20
D-F:SEQ ID NO:21
D-R:SEQ ID NO:22
E-F:SEQ ID NO:23
E-R:SEQ ID NO:24。
the sequence of the CMV promoter is shown as SEQ ID NO. 8, and the sequence of the HDV-BGH gene is shown as SEQ ID NO. 9.
The primers for PCR amplification of the CMV promoter and the HDV-BGH gene are respectively as follows:
CMV-F:SEQ ID NO:25
CMV-R:SEQ ID NO:26
HDV-F:SEQ ID NO:27
BGH-R:SEQ ID NO:28。
in the step (5), the molar ratio of the 5 gene segments to the intermediate vector pBAC-M-PDCoV is 1:2:2:1:1: 1.
The method comprises the following specific steps:
(1) extracting RNA of a PDCoV CHN-HN-2014 strain and preparing cDNA;
(2) amplification and cloning of related genes of the PDCoV CHN-HN-2014 strain: the cDNA is taken as a template, and PCR amplification is carried out by utilizing primer pairs PDCoV-5 '-F/R (SEQ ID NO:11, SEQ ID NO:12), PDCoV-3' -F/R (SEQ ID NO:13, SEQ ID NO:14), A-F/R (SEQ ID NO:15, SEQ ID NO:16), B-F/R (SEQ ID NO:17, SEQ ID NO:18), C-F/R (SEQ ID NO:19, SEQ ID NO:20), D-F/R (SEQ ID NO:21, SEQ ID NO:22), E-F/R (SEQ ID NO:23, SEQ ID NO:24) to obtain corresponding gene segments. Wherein, A (348) and 4538 and 4191bp), B (4519 and 9652 and 5134bp), C (9633 and 15132 and 5500bp), D (15113 and 19455 and 4343bp) and E (19436 and 23403 and 3968bp) gene fragments contain 20bp homologous sequences, and in addition, 15121 site C is silenced and mutated into A by primer design, a ClaI endonuclease sequence (ATCGAT) is eliminated, and the ClaI endonuclease sequence is used as a genetic marker to distinguish the parental virus from the recombinant virus. PCR amplification is respectively carried out by taking pBAC-AJ1102(PEDV AJ1102 strain cDNA clone plasmid, stored in a laboratory) constructed in a laboratory as a template and CMV-F/R (SEQ ID NO:25, SEQ ID NO:26) and HDV-F/BGH-R (SEQ ID NO:27, SEQ ID NO:28) as primer pairs to obtain a CMV promoter and an HDV-BGH gene sequence. These gene fragments were cloned into pJET1.2/blunt vector for sequencing analysis, and the plasmids were named pJET1.2-CMV, pJET1.2-PDCoV-5 '(1-375), pJET1.2-PDCoV-3' (23365-25421bp), pJET1.2-A, pJET1.2-B, pJET1.2-C, pJET1.2-D, pJET1.2-E, and pJET1.2-HDV-BGH, respectively.
(3) Construction of intermediate vector (pBAC-M-PDCoV): cloning CMV promoter, 5 'end gene sequence (1-375bp, 3' end containing AvrII restriction endonuclease), 3 'end gene sequence (23365-25421bp, 5' end containing BamHI restriction endonuclease), poly (A) structure of 27 adenine deoxynucleotides (A), hepatitis C virus (HDV) ribozyme self-cutting site and bovine growth hormone termination sequence (BGH) into a low-copy vector pBeloBAC11 by using ApaLI and HindIII restriction endonuclease and a multi-step fusion PCR method to obtain an intermediate vector pBAC-M-PDCoV;
(4) construction of a full-length cDNA cloning plasmid (pBAC-CHN-HN-2014) of the PDCoV CHN-HN-2014 strain: PCR amplification of 5 gene fragments, A (SEQ ID NO:3), B (SEQ ID NO:4), C (SEQ ID NO:5), D (SEQ ID NO:6), E (SEQ ID NO:7), each containing 20bp of homologous sequence between each fragment, using the correctly sequenced pJET1.2-A, pJET1.2-B, pJET1.2-C, pJET1.2-D, pJET1.2-E plasmids as templates, A-F/R (SEQ ID NO:15, SEQ ID NO:16), B-F/R (SEQ ID NO:17, SEQ ID NO:18), C-F/R (SEQ ID NO:19, SEQ ID NO:20), D-F/R (SEQ ID NO:21, SEQ ID NO:22), E-F/R (SEQ ID NO:23, SEQ ID NO:24) as primer pairs, wherein, 20bp homologous arms exist at the 5 'end of the A fragment and the 3' end of the E fragment and the two ends of pBAC-M-PDCoV linearized by AvrII and BamHI respectively. Then, 5 fragments are cloned into pBAC-M-PDCoV in one step through homologous recombination according to a certain proportion to obtain the recombinant plasmid pBAC-CHN-HN-2014.
(5) Transforming the recombinant product into DH10B chemically competent cells, and screening positive clones by using PCR;
(6) carrying out amplification culture on positive clones with correct sequencing, and extracting plasmids;
(7) the extracted plasmid was transfected into LLC-PK1 cells using Lipofectamine 3000 for 4h, and then replaced with serum-free DMEM medium containing 10. mu.g/mL of pancreatin, and the cytopathic effect was observed day by day.
The invention has the beneficial effects that:
the invention provides a PDCoV CHN-HN-2014 strain full-length cDNA infectious clone plasmid and a recombinant virus rCHN-HN-2014 method which are quickly obtained based on a BAC system and a homologous recombination one-step cloning method, and provides a powerful technical platform for deeply researching genetic variation of PDCoV, a potential cross-species propagation mechanism, a virulence gene, a virus infection and pathogenesis, vaccine development and the like. The invention also has the advantages of high homologous recombination efficiency, high positive colony content, short period and the like.
Drawings
FIG. 1: schematic diagram of construction of infectious clone of porcine delta coronavirus CHN-HN-2014 strain.
FIG. 2: pictures of the rescued virus rchnn-HN-2014 were identified by indirect Immunofluorescence (IFA). Description of the drawings: a, picture A: pictures under an inverted microscope of normal virus-uninfected LLC-PK1 cells; and B, drawing: a picture of LLC-PK1 cells infected by a PDCoV wild-type virus CHN-HN-2014 strain under an inverted microscope; and (C) diagram: images of LLC-PK1 cells infected with the PDCoV rescue virus rCHN-HN-2014 strain under an inverted microscope.
FIG. 3: RT-PCR analysis identifies pictures of genetic markers.
FIG. 4: DNA sequencing analyzes pictures of genetic markers.
FIG. 5: the PDCoV rCHN-HN-2014 strain is compared with the CHN-HN-2014 strain in vitro with one-step growth curves.
FIG. 6: rCHN-HN-2014 was compared to CHN-HN-2014 for the plaque phenotype formed on LLC-PK1 cells.
Detailed Description
The present invention is described in detail below with reference to specific examples, but the scope of the present invention is not limited thereto.
Example 1:
1. the formula of the main test materials, carriers, plasmids, reagents and related culture media or solutions:
PDCoV CHN-HN-2014 strain: the virus is separated, identified and stored by the national emphasis laboratory of agricultural microbiology of university of agriculture in Huazhong in different rooms (Dong N, Fan L, Yang H, Liu H, Du T, Fan P, Wang D, Chen H, Xiao S.isolation, genomic characterization, and clinical importance of a Chinese pesticide deltacononavir strain CHN-HN-2014.Vet Microbiol.2016,196: 98-106). Whole genome sequences such as GenBank accession No.: KT 336560.
pBAC-AJ1102 is an infectious clone containing the full-length cDNA of PEDV AJ1102 strain: the virus is constructed and stored in different rooms for the national key laboratory of agricultural microbiology of Huazhong university of agriculture.
LLC-PK1 cell: purchased from American Type Culture Collection (ATCC).
Chloramphenicol (cat # BS 049B): purchased from Biosharp corporation.
Various restriction enzymes: purchased from New England Biolabs.
DMEM medium, T4 DNA ligase (cat # 15224025), Lipofectamine 3000 (cat # L3000015), pJET1.2/blunt vector were purchased from Thermofisiher Scientific, USA.FastPfu DNA Polymerase was purchased from TransGen Biotech. Transcriptor Reverse Transcriptase (cat # 39083420).
Fetal bovine serum (FBS, cat # P30-3302): purchased from PAN Biotech, usa.
Cycle Pure Kit (cat # D6492-02), Gel Extraction Kit (cat # D2500-02): purchased from Omega Bio-tek, USA.
Infusion Clone Kit (cat # 639648), Plasmid DNA purification Kit (cat # 740410.50): purchased from TAKARA corporation.
DH10B chemically competent cells: purchased from Shanghai super research Biotechnology, Inc.
The pBeloBAC11 vector (cat # P1028) was purchased from Shanghai grain, noon Biotech, Inc.
Preparing an LB culture medium: weighing 5g peptone, 2.5g yeast extract, 5g NaCl in 1L Erlenmeyer flask, adding ddH2And O is added to 500mL, and the mixture is autoclaved at 121 ℃ for 20 min.
2. Construction of infectious clone plasmid of porcine delta coronavirus CHN-HN-2014 strain
2.1 extraction of PDCoV CHN-HN-2014 strain RNA and preparation of cDNA
The genome RNA of the PDCoV CHN-HN-2014 strain is extracted by using a TRIzol reagent. Taking the extracted RNA as a template, and carrying out reverse transcription by using a Transcriptor First strand cDNA synthesis Kit to obtain cDNA, wherein the reverse transcription conditions are as follows: 1 μ 1 oligo (dT)18 or fragment specific downstream primer, 12 μ L of extracted RNA, supplemented with ddH2O to the total volume of 13 mu L, uniformly mixing, incubating for 10min at 65 ℃, incubating for 5min on ice, adding 4 mu L of 5 × RT reaction buffer, 2 mu L of dNTP mixture, 0.5 mu L of RNase inhibitor and 0.5 mu L of Transcriptor Reverse Transcriptase, incubating for 30min at 55 ℃, and incubating for 10min at 85 ℃ to obtain cDNA for subsequent experiments.
2.2 amplification and cloning of related genes of PDCoV CHN-HN-2014 strain
PDCoV CHN-HN-2014 strain cDNA is taken as a template, and PCR amplification is respectively carried out on PDCoV-5 '-F/R (SEQ ID NO:11, SEQ ID NO:12), PDCoV-3' -F/R (SEQ ID NO:13, SEQ ID NO:14), A-F/R (SEQ ID NO:15, SEQ ID NO:16), B-F/R (SEQ ID NO:17, SEQ ID NO:18), C-F/R (SEQ ID NO:19, SEQ ID NO:20), D-F/R (SEQ ID NO:21, SEQ ID NO:22), E-F/R (SEQ ID NO:23, SEQ ID NO:24) by utilizing primer pairs to obtain corresponding gene fragments. Wherein, the A (SEQ ID NO:3), B (SEQ ID NO:4), C (SEQ ID NO:5), D (SEQ ID NO:6) and E (SEQ ID NO:7) gene segments contain 20bp homologous sequences, and in addition, the 15121 site C is artificially silenced and mutated into A by primer design, so that a ClaI endonuclease sequence (ATCGAT → ATAGAT) is eliminated as a genetic marker. The PCR reaction system is as follows: 10 μ L of 5 XPCR reaction buffer, 4 μ L of dNTP mix, 10 μ M of upstream and downstream primers, 2 μ L of cDNA template, FastPfu DNA Polymerase 1. mu.L, plus ddH2O to a total volume of 50. mu.L. The reaction conditions were as follows: 2min at 95 ℃; 20s at 95 ℃; 20s at 95 ℃,20 s at 58 ℃ and 2min at 72 ℃; after 34 cycles, extension was carried out for 5min at 72 ℃. After the reaction is finished, the amplification product is subjected to 1% agarose Gel electrophoresis, and then is recovered by using Gel Extraction Kit according to the instruction, and the recovered product is the gene segment related to the virus.
PCR amplification is respectively carried out by taking pBAC-AJ1102(PEDV AJ1102 strain cDNA clone plasmid) constructed in a laboratory as a template and CMV-F/R (SEQ ID NO:25, SEQ ID NO:26) and HDV-F/BGH-R (SEQ ID NO:27, SEQ ID NO:28) as primer pairs to obtain a CMV promoter and an HDV-BGH gene sequence.
The obtained gene fragments are respectively cloned into pJET1.2/blunt vector (Thermo scientific) for sequencing analysis, the authenticity of the sequence is ensured, and the fragment cloning reaction system is as follows: 5 mu.L of 2 × Reaction buffer, 4 mu.L of PCR product, 0.5 mu.L of pJET1.2/blunt vector and 0.5 mu. L T4 DNA ligase, the total volume is 10 mu.L, the temperature is 25 ℃ for 30min, then DH5 alpha is transformed, positive clones are picked and sent to Wuhan Pongson biotechnology Limited for sequencing, and positive plasmids are extracted and named as pJET1.2-CMV, pJET1.2-PDCoV-5 '(1-375), pJET 1.2-PDCoV-3' (23365 + 25421bp), pJET1.2-A, pJET1.2-B, pJET1.2-C, pJET1.2-D, pJET1.2-E, pHDT 1.2-V-BGH.
2.3 construction of the intermediate vector pBAC-M-PDCoV:
2.3.1 amplification of the intermediate fragment (M-PDCoV): the fusion fragment 1 is obtained by overlapping extension PCR method of CMV gene fragment obtained by amplification of the CMV-F/R (SEQ ID NO:25, SEQ ID NO:26) primer pair and PDCoV CHN-HN-2014 strain PDCoV 5 'end (1-375bp) gene fragment obtained by amplification of PDCoV-5' -F/R (SEQ ID NO:11, SEQ ID NO:12) primer pair. Overlap extension PCR system: 10 μ L of 5 XPCR reaction buffer, 4 μ L of dNTP mix, 10 μ M of upstream and downstream primers (CMV-F/PDCoV-5 '-R), 2 μ L of DNA template (equimolar amounts of CMV and PDCoV-5'), fastpfu DNA Polymerase 1. mu.L, plus ddH2O to a total volume of 50. mu.L. The reaction conditions were as follows:2min at 95 ℃; 20s at 95 ℃; 20s at 95 ℃,20 s at 58 ℃ and 2min at 72 ℃; after 34 cycles, extension was carried out for 5min at 72 ℃. After the reaction is finished, the amplification product is subjected to 1% agarose Gel electrophoresis, and then is recovered by using Gel Extraction Kit according to the instruction, and the recovered product is the fusion fragment 1.
Obtaining a fusion fragment 2 by overlapping extension PCR method of a PDCoV CHN-HN-2014 strain 3 'end (23365-plus 25421bp) gene fragment obtained by amplifying a PDCoV-3' -F/R (SEQ ID NO:13, SEQ ID NO:14) primer pair and an HDV-BGH gene fragment obtained by amplifying an HDV-F/BGH-R (SEQ ID NO:27, SEQ ID NO:28) primer pair; finally, the fusion fragments 1 and 2 are subjected to an overlap extension PCR method to obtain an intermediate fragment M-PDCoV (SEQ ID NO:10), and both ends of the intermediate fragment respectively contain ApaLI and HindIII restriction endonuclease sequences.
2.3.2 cloning of the intermediate fragment M-PDCoV into the pBeloBAC11 vector: the pBeloBAC11 vector and the intermediate fragment M-PDCoV were subjected to ApaLI and HindIII double digestion for 2h, subjected to 1% agarose Gel electrophoresis, and then recovered with Gel Extraction Kit according to the instructions. T4 DNA ligase is used for ligation, and the ligation reaction system is as follows: M-PDCoV 200ng, linearized pBeloBAC11 vector 200ng, 1 mu LT4 DNA Ligase, 1 mu L10 XLigase buffer with the total volume of 10 mu L and the temperature of 22 ℃ for 5h, then DH10B competence is transformed, positive clone is picked up, plasmid is extracted, and the obtained plasmid is named pBAC-M-PDCoV.
2.4 digestion and recovery of pBAC-M-PDCoV: pBAC-M-PDCoV was subjected to double digestion with AvrII and BamHI from NEB, and the digestion reaction system and conditions were as follows: 2.5. mu.g of pBAC-M-PDCoV, 2. mu.L each of AvrII and BamHI, 3. mu.L of 10 × reaction buffer, supplemented with ddH2O to a total volume of 30. mu.L, mixing, and incubating at 37 ℃ for 2 h. The recovery was performed with the Cycle Pure Kit according to the instructions. Wherein, 20bp homologous arms exist at the two ends of the pBAC-M-PDCoV linearized by AvrII and BamHI and at the 5 'end of the A fragment and the 3' end of the E fragment respectively.
2.5 linearized pBAC-M-PDCoV was subjected to homologous recombination with 5 fragments to clone in one step:
2.5.1 taking pJET1.2-A, pJET1.2-B, pJET1.2-C, pJET1.2-D and pJET1.2-E plasmids with correct sequencing as templates and taking A-F/R, B-F/R, C-F/R, D-F/R and E-F/R as primersPCR amplification is carried out to obtain corresponding fragments. The reaction system is as follows: 10 μ L of 5 XPCR reaction buffer, 4 μ L of dNTP mix, 10 μ M of upstream and downstream primers, 2 μ L of cDNA template, fastpfu DNA Polymerase 1. mu.L, plus ddH2O to a total volume of 50. mu.L. The reaction conditions were as follows: 2min at 95 ℃; 20s at 95 ℃; 20s at 95 ℃,20 s at 58 ℃ and 2min at 72 ℃; after 34 cycles, extension was carried out for 5min at 72 ℃. After the reaction is finished, the amplification product is subjected to 1% agarose Gel electrophoresis, and then is recovered by using Gel Extraction Kit according to the instruction, and the recovered product is used for subsequent homologous recombination experiments.
2.5.2 Infusion reaction System was constructed using In-Fusion PCR Cloning Kits: mixing 5 gene fragments (A, B, C, D, E) with different proportions and the pBAC-M-PDCoV vector (F fragment) linearized In the step (4) uniformly, adding 4 mu L of 5 XIn-Fusion Enzyme Premix with the total volume of 20 mu L and the temperature of 50 ℃ for 30min, then incubating for 2min on ice, taking 5 mu L of the transformant DH10B competence, and carrying out positive clone screening. We tried recombination with different molar ratios of fragments (A, B, C, D, E, F) and found that homologous recombination with the most commonly used ratio (1:1:1:1:1:1) produced very few positive colonies, only about 2%; for this purpose, we further adjust the ratio, including (1:1:1:1:1:2), (1:1:1:1:2:1), (1:1:1:2:1:1), (1:2:1:1: 1), (2:1:1:1:1:1), and find that increasing the ratio of the B fragment or the C fragment significantly increases the positive rate of the colony, reaching about 30% and 36%, respectively; meanwhile, the proportion of B and C is increased (1:2:2:1:1:1), the positive rate of the colony can reach 65%, which shows that the increase of the proportion of the B fragment and the C fragment is favorable for improving the efficiency of one-step homologous recombination; we further tried to increase the proportion of other fragments on the basis of this, and found that the rate of positive colonies was not increased but decreased. In addition, the ratio of the B fragment to the C fragment is simultaneously increased on the basis of the ratio (1:2:2:1:1:1) (1:4:4:1: 1), the positive rate of colonies is not increased again, but is reduced, which is probably the unique property of the PDCoV gene fragment, and the previous research does not report.
2.6 conversion of ligation products: mu.L of the ligation product from step (2.5.2) was added slowly to 100. mu.L of DH10B chemocompetent cells, gently mixed and left to stand in an ice-water bath for 30 min. After heat shock at 42 ℃ for 60s, the cells were immediately placed in an ice-water bath for 2min, 600. mu.L of LB medium was added, and the cells were thawed at 37 ℃ and 180rpm for 1 h. After completion of the recovery, centrifugation was carried out at 5000rpm for 5min, 500. mu.L of LB medium was discarded, and competent cells were suspended with the remaining LB medium and plated on LB solid plates containing 25. mu.g/mL of chloramphenicol. After 10min, the plate was placed upside down in an incubator at 37 ℃ and cultured for another 15 h.
2.7 screening of Positive clones: a plurality of colonies were picked up and cultured in a bacterial flask containing 1mL of LB at 37 ℃ for 8 hours at 225rpm, and then the gene sequences containing the genetic markers were PCR-amplified using the primers Clone-F and Clone-R for identification. The PCR conditions were as follows: 2 XTaq Master Mix 12.5. mu.L, upstream and downstream primers 10. mu.M each, 1. mu.L of bacterial solution, and ddH2O to a total volume of 25. mu.L. The reaction conditions were as follows: pre-denaturation at 95 ℃ for 3 min; 30s at 95 ℃, 30s at 58 ℃ and 1min at 72 ℃; after 25 cycles, extension was carried out for 5min at 72 ℃. After the reaction is finished, 8 mu L of the mixture is subjected to electrophoresis by using 1% agarose gel to identify positive clones, the bacteria identified as the positive clones are sent to Wuhan Pongzi biotechnology limited company for sequencing, and the plasmids of the positive clones are named as pBAC-CHN-HN-2014.
2.8 extraction of pBAC-CHN-HN-2014 plasmid: after the colony identified as positive in step (2.7) was expanded and cultured, the Plasmid pBAC-CHN-HN-2014 was extracted in large quantities with the Plasmid DNA purification Kit according to the instructions. The last step was performed with 100. mu.L ddH2Eluting with O, and storing at-20 deg.C for use.
2.9 rescue of recombinant virus rCHN-HN-2014: mu.g of recombinant plasmid pBAC-CHN-HN-2014 was transfected to 80% confluency LLC-PK1 cells with Lipofectamine 3000 according to the instructions. After 4h of transfection, the culture medium is changed into serum-free DMEM containing 10 mug/mL pancreatin, the culture is continued until more than 80% of cells are diseased, the cell culture is harvested, the cells are frozen and thawed for 2 times at minus 70 ℃, the cells are centrifuged for 5min at 2000rpm, and the supernatant is taken and inoculated with LLC-PK1 cells for subculture.
As a result: 48 hours after the cDNA clone pBAC-CHN-HN-2014 transfects LLC-PK1 cells, the cells have obvious lesions which are mainly manifested as cell rounding, aggregation and shedding and are consistent with the cell lesions caused by wild PDCoV CHN-HN-2014 strains, which indicates that the virus rescue is successful, and the cDNA clone pBAC-CHN-HN-2014 is named as rCHN-HN-2014. Indirect immunofluorescence experiments show that specific green fluorescence can be observed in cells infected by both the recombinant virus and the wild type virus, the control cells have NO specific fluorescence (figure 2), virus RNA is further extracted to identify the genetic marker (SEQ ID NO:29), the RT-PCR product from the wild type virus is cut into two bands (364bp and 716bp) by ClaI enzyme, but the RT-PCR product from the recombinant virus cannot be cut (figure 3), the results are further verified by DNA sequencing, and the 15121 site C is mutated into A to eliminate the ClaI enzyme cutting site in the RT-PCR product from the recombinant virus (figure 4). These results confirm the success of the virus rescue. The obtained recombinant virus is continuously transmitted for 5 generations on LLC-PK1 cells, cytopathic effect can be stably observed, RT-PCR analysis proves that genetic markers stably exist, and the recombinant virus rCHN-HN-2014 has stable proliferation capacity. At the same time, further analysis of the in vitro biological properties of the recombinant and parental viruses revealed that rCHN-HN-2014 had a similar growth curve (fig. 5) and plaque size and morphology (fig. 6) as the parental virus.
Wherein, the primers used for obtaining the 1080bp genetic marker-containing gene fragment by amplification are as follows:
the upstream primer Clone-F: 5'-CCAAGTTGGTGATTACATTC-3'
The downstream primer Clone-R: 5'-GCTGAGTCAGTGGTCACGCA-3' are provided.
The invention provides a method for quickly obtaining a PDCoV CHN-HN-2014 strain full-length cDNA infectious clone plasmid and a recombinant virus rCHN-HN-2014 based on a BAC system and a homologous recombination one-step cloning method. Provides a powerful technical platform for deeply researching the genetic variation of the PDCoV, a potential cross-species propagation mechanism, a virulence gene, a virus infection and pathogenesis mechanism, vaccine development and the like.
Description of sequence listing:
1, SEQ ID NO: PDCoV CHN-HN-2014 strain 5' end gene sequence.
2, SEQ ID NO: PDCoV CHN-HN-2014 strain 3' end gene sequence.
3, SEQ ID NO: fragment A gene sequence.
4, SEQ ID NO: b fragment gene sequence.
5, SEQ ID NO: c fragment gene sequence.
6 of SEQ ID NO: d fragment gene sequence.
7, SEQ ID NO: e fragment gene sequence.
8, SEQ ID NO: CMV promoter gene sequence.
9 of SEQ ID NO: HDV-BGH gene sequence.
10, SEQ ID NO: an intermediate fragment M-PDCoV gene sequence comprising: the CMV promoter, a PDCoV CHN-HN-2014 strain 5 'end gene sequence, a PDCoV CHN-HN-2014 strain 3' end gene sequence, 27A poly (A) structures, an HDV gene sequence and a BGH gene sequence.
11, SEQ ID NO: and amplifying a forward primer (PDCoV-5 '-F) sequence of the 5' end gene.
12, SEQ ID NO: and amplifying a downstream primer (PDCoV-5 '-R) sequence of the 5' end gene.
13 in SEQ ID NO: and amplifying a forward primer (PDCoV-3 '-F) sequence of the 3' end gene.
14, SEQ ID NO: and amplifying a downstream primer (PDCoV-3 '-R) sequence of the 3' end gene.
15, SEQ ID NO: the upstream primer (A-F) sequence of the A fragment gene was amplified.
16 in SEQ ID NO: amplifying the downstream primer (A-R) sequence of the A fragment gene.
17 in SEQ ID NO: and amplifying the upstream primer (B-F) sequence of the B fragment gene.
18, SEQ ID NO: and amplifying the downstream primer (B-R) sequence of the B fragment gene.
19, SEQ ID NO: and amplifying the upstream primer (C-F) sequence of the C fragment gene.
20, SEQ ID NO: and amplifying a downstream primer (C-R) sequence of the C fragment gene.
21, SEQ ID NO: and amplifying an upstream primer (D-F) sequence of the D fragment gene.
22, SEQ ID NO: amplifying the downstream primer (D-R) sequence of the D fragment gene.
23, SEQ ID NO: and amplifying the upstream primer (E-F) sequence of the E fragment gene.
24, SEQ ID NO: and amplifying the sequence of a downstream primer (E-R) of the E fragment gene.
25 in SEQ ID NO: the upstream primer (CMV-F) sequence of the CMV promoter was amplified.
26, SEQ ID NO: the downstream primer (CMV-R) sequence of the CMV promoter was amplified.
27 of SEQ ID NO: the sequence of the upstream primer (HDV-F) of the HDV-BGH gene is amplified.
28, SEQ ID NO: and amplifying a downstream primer (BGH-R) sequence of the HDV-BGH gene.
29 in SEQ ID NO: a gene sequence comprising a genetic marker.
Sequence listing
<110> university of agriculture in Huazhong
<120> method for constructing infectious clone plasmid of porcine delta coronavirus
<160> 29
<170> SIPOSequenceListing 1.0
<210> 1
<211> 375
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 1
acatggggac taaagataaa aattatagca ttagtctata attttatctc cctagcttcg 60
ctagttctct accgacacca atccaggtgc gtctgccacc aagttggcta ccctttctag 120
gggcgctttt gcgcttgctc accattagat tacctggaaa ccagccattc aggttggagt 180
ttccccaggc acttttgcgt gggcattagc ggcttgtggt ttttgcacaa aatctaagct 240
acttaccgtt cctctgacca ttcaccactt ctatagacag cactgactac cgtagggttc 300
aagtcacacc ggtctgcacc gcccgtcagc ggacacatta cccagcatag cactccttgc 360
<210> 2
<211> 2057
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 2
cttgcaggga ttatggatcc aatgggtaca tggaggtgca ttcccatcga ccacatggct 60
ccaattctca caccagtcgt taagcatggc aagctcaagc tacatgggca agagctggcc 120
aatggcatat cagtcagaaa tccgccacag gatatggtga tagtgtcacc aagtgacacc 180
tttcactaca cttttaagaa acctgtggaa tcaaacaacg atccagaatt cgctgttctg 240
atataccagg gtgaccgcgc ttcaaacgct ggacttcaca ccataaccac ttcaaaggcc 300
ggtgacgctc gcctgtataa gtatatgtaa tgtgcaactg ccacctgcag ctgcgagatt 360
tatatagatt gtgcaataag cggcacatca gaagagagga tgttcctgag cttattgacc 420
ctctcgttaa aactcgctgt tttgcttaca gtctcgtggt tcttgctaat gctaatccaa 480
ttgcatttag catactacct cggaaacttc ttatcaatgg tgagccttta ctgcttgaat 540
atggtagcat atatggtaaa gactttatca ttcgaccatc gctccaagtc attcttgaag 600
atgaattaaa ttaaagtttt gacaccaatc tatcatggct gcaccagtag tccctactac 660
tgacgcgtct tggtttcagg tgctcaaagc tcaaaacaaa aaagccattc atcctcagtt 720
tcgtggcaat ggagttccgc ttaactccgc catcaaaccc gttgaaaatc atggctactg 780
gctgcgttac accagacaaa agccaggtgg tactccgatt cctccatcct atgcctttta 840
ttatactggc acaggtccca gaggaaatct taagtatggt gaactccctc ctaatgatac 900
cccagcaacc actcgtgtta cttgggttaa gggttcggga gctgacactt ctattaagcc 960
tcatgttgcc aaacgcaacc ccaacaatcc taaacatcag ctgctacctc tccgattccc 1020
aaccggagat ggcccagctc aaggtttcag agttgacccc ttcaacgcta gaggaagacc 1080
tcaggagcgt ggaggtggcc caagatctca atctgttaac tccagaggca caggcaatca 1140
gcctaggaaa cgcgaccaat ctgcacccgc tgcggtacgt cgtaagaccc aacatcaagc 1200
tcccaagcgg actttaccta agggtaaaac catttctcag gtatttggca accggtctcg 1260
tactggtgcc aatgtcggct ctgcagacac tgagaagacg ggtatggctg atcctcgcat 1320
catggctcta gccagacatg tgcctggtgt tcaggaaatg cttttcgctg gtcacctcga 1380
gagcaacttt caggcggggg caattaccct taccttctct tactcaatca cagtcaagga 1440
gggttctcct gactatgaga gacttaagga tgcgctcaac acggtcgtta accagaccta 1500
tgagccaccc accaaaccaa ctaaggacaa gaagcctgac aaacaagacc agtctgctaa 1560
atccaaacag cagaagaaac ctaaaaaggt aactctgcca gcagacaaac aggattggga 1620
gtgggatgat gcttttgaga taaagcagga atcagcagcg tagacatcaa tctatgtctg 1680
ttaaacccac ccaactccac tcaaatatct ctttggttcc agagagtcgt agtgtatagc 1740
cagagagcca gtcagagggc gctatcatgc aaactagggc tggctactct agcacagaat 1800
cacatcccga taatcaacag tgctagaagg ttgattatac catttaatat gccgaggcca 1860
cgcggagtac gatcgagggt acagcataat ctcaactttt gttgagccac aattttaatc 1920
ctaattggag aaggccaaag gactgtacta cttctgtagg tgtagcagtc gcccagtggg 1980
aaagcgccaa ctaggttaca attgtggtgg ggacaaatta ggggaaatta aattggctta 2040
taggggggat ggagcaa 2057
<210> 3
<211> 4191
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 3
tagcactcct tgcaccgagc ctaggtagga taaaaccccc taccgggtga ctcttaaggc 60
ctttcctcca cgggatagct actagtcact aggtgtaagt gatctgatct gggcgtattg 120
tgttgcgcaa gtgtgatacc cataggagcg tggaatccta ttctgcggct cagtgcctga 180
tatagctgtg aaatggccaa gaacaagtcc aagcgcgacg ctatcgcgtt gcctgaaaat 240
gtaccaccac ctctgcaact tttcattcac gttgcagctg ctgaagaggg tcaccctaag 300
gttactactt accttggcaa ctataacctc tatgccacca aggctccgcc tggcgtgcag 360
gttcttagtg ctaaaacctc tcttactgac tttgagaatg tctttggagc ccaacccacc 420
ttgcgatcaa ttcgtaatct ggtttgtgag gctcgctcgg ctgaatggac aacttccaag 480
aatgcttttg cactcaaagc cactcaactt gactactctg atgccgtttt gagggcaatg 540
attcgtttct gccctccaaa ggtgtccaca ctcgctgcct ttgctctttt tggcagattg 600
gttaaaattg aggacaagga acttgctgag ttagctcgtg acactgccct tgagttggcg 660
tacacggcta aaattggtac atctcttgct gacacgagat ctgtctcact tattcataag 720
gacgcttatc taactctcag taatgaggtt gttggcgtaa cttttactgc cgcacttatg 780
gcaaaggcta ccactgttaa tggagcaatg caatactcaa acttttacct ctaccctcgt 840
gccactatta aggtgaccga tggtaaggtt gaagcaattg caaccaagcc tctttctgct 900
gctactaaag gcaagcaaat cacagaggat gtcaaccttc tccctgacta tcagcagctg 960
cttgttgatc aagtgactgg cactgaggtt aaggttggag ctttaaccta tgttaagacc 1020
actgattcac caccccttta ctttcccaaa gtcaagggtg gtgttattgg tattgcactt 1080
aagcagcagg gcactgcggc taagaagctc aatgtagtct tccatgctca acctgatgat 1140
gttctgctag ccttcataca acttcagcaa ttcttgaacc gtacttcgga ttcaagtgtt 1200
gaaattactg gttgccagag ttatgaagta tctccaactg tgactgtcaa aattggcccg 1260
tctaaacctg gggatgtcat cgtggctact gatgaggaat accttaaatg ctttgaaacc 1320
cctgaggtag gtaggctcta taaggttttc caaactcaat cttgggctat cattgagcgt 1380
tccttctcca gtttgaagat ccgcgtgtcc aaagctttat cagcatttat aagttttctg 1440
caaaaccttg cagataactt tactgcaata agtggtgttg tcactgcact cattcgtgaa 1500
ctccaggatc ttaccctgga tgtggcgaca cgtatcacta acatacaatt tgtttaccgt 1560
gccggtaagc ttattgtcga cactacaagt gtcatagcta aacttttcca gccattctgt 1620
gattttatat cacctttcct tcggaaagtt gctggttttg caatttacac tgttggtaat 1680
cgcatgctta tgtttaccag caccggcacc tttcttctta caagggcaac tactaagata 1740
ctcaataagg caaagtacat ctttgatgtg gagcctgagt acccagtaga tgtaacaaca 1800
tccaaagttg tagtacatga agcactccag caaaccgaca ctaagcctac tagagctcta 1860
gaggctgttg atgtcgttgt tggtaatact gtactgcaaa tggctactga tggcactgcg 1920
ttctacccat cggatggtac gcacgcctct cttccaggat tcaaagcagg ctcggatgag 1980
ctttttataa gcttcaactg cgacctcttt gatgatgaga ctaatgctca aatcaacgaa 2040
acactcgctg catatgagct taaccaacta gtggctccag gtgattctac accgcgtcaa 2100
attgcgacgt tggttgtcga tacacttgta gatgctataa cagaccactt tccggagaaa 2160
accattgatc tacctgaaga ctatcaagtc ttttctgacc atgatgatct cccactcgca 2220
caataccaca tccctgatca cctgagcctg tatattcagg ctatggaagg tgaagatgat 2280
agtggtgatg aaatatgtat tgaggacgat gattacgact gtcctcaagc cgacgaagac 2340
acagaaggag taattcccca acagtgggaa cttcctgatg ttgataaatt tttactcaag 2400
atccaggaac ggaagaccag cagcgacgaa gtacttagcg tcgacgtcta tcctaaacca 2460
gagccagtcg gcaatgttgg gattgacgac agcgcgtcgg aaaagaagcc aaatggggac 2520
tcagtaccgg atcctgaggt ccatccaaca ctagagagtg tggatgttga acgaccaacc 2580
gaaacagcaa accaggctgt tgaagacaaa ccttctgata ccacctttgt ggttgatgag 2640
gaacaattac aagaatcaac accagaacat gaactccgct cctatgaggg ggagtttgat 2700
tctgatgatg aaattattat tcctatagta ccagtaacac ctgcggattt aaaaccacag 2760
actattacta taaaggagta ctttaagtct gaaaaacttg agactattaa cgaaggatcc 2820
acagagtcag ttacacaatc tgacgattcg tttgacgagt catttgttga tgctgagtct 2880
gatgatccac aagatcctgc tgtatatgat gatacaacaa ttataacgga cagtactgat 2940
gtaggcgatg agcctgagac aactctagct accatcgtta acacacctct gacactcgat 3000
aataacttgc cacctgaagc cattaaacaa cccagcccga ctaaggttga gttagttgtt 3060
ggcgaattgg caagtattaa atttgacaat tctgtcctag tcaaccctgc taatgcgcaa 3120
ttaacaaatg gcggtggagc tgcccgtgca attgcaaagt tagctggtcc aaaataccaa 3180
gagtactgta atagtgtggc tcctatctca ggaccgctta ccacggactc ttttgatgcc 3240
aagaaacttg gtgtagcctg catcttgcat gtagtgccac ccaaaggttc tgaccctaat 3300
gtacaagaac tcctgtatca agcttacaag agtatcctta ctgaaccagc acactatgtt 3360
atacctatac taggtgctgg tatctttgga tgcaacccag tccactctct ggatgcgttc 3420
aggaaagcat gtccaagtga cataggtcgt gtcacccttg tcactatgaa caaaaaccat 3480
ttgcaggtgt gggatgctct caataggacc attgtacgca ccactactga ctatgatcaa 3540
gttaccacca aggcccttac accccaggga gtgttagaag ccaatctctt tgatggtgag 3600
gactttgttc aagaaccaaa acccggtcaa atttaccttg aggttactga agaagttcag 3660
aaccaagcca aggaacttga ccttaacctt cagcaatact gcgtctacct gaagacttgc 3720
caccataaat gggttgtgag tcgtacgaac gggttgatgc atctaaaaca aaaagataac 3780
aattgttttg ttagtgcagg tgtaaacttg tttcaaaaca ctgcttatca atttagacct 3840
gctattgatg ctctctatag ggagtatctc aatggtaatc caaacagatt tgttgcttgg 3900
atctacgcat ccactaaccg tcgtgttggt gagatgggtt gtccacagca agttatttct 3960
ttgctcgtta gtaactctga cgcagcattt tcagcaacta cagcctgttg taacacctac 4020
tttaaccaca caggtgttat ttcagtagct cgtgaatatg acccaataca accaaaggtc 4080
tactgcatga agtgcgatgt gtggactccc tttacacccc agagtggaaa aggtgcagtt 4140
gcaattggta cttctgcaga tgaacctacc ggtcctgcca ttaaatttgc c 4191
<210> 4
<211> 5134
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 4
gtcctgccat taaatttgcc gcagctcact gctggtacac taatggcaag aaaacagtta 60
atggctatga cactaaagct aatgttgtag ctacttatca taggtttgac gtgcctaagc 120
ctcaacttgt cgaggacgtg gttgcgctgc ctactaaaaa tgactttgaa gttctcaatg 180
ttgaagaact gccacaggat agtgtgctcc atttggaccc acctcctgta caggccttac 240
aacctaaggc taaccaacac attgagattt tagaaaaccc agattatctg gacattttgg 300
atctttggat tcgtaaaccc aaattcatcc tcgtaaagtc gtggagtgtt ttgggtagag 360
cactatgtaa ggcaggtaaa gttgtctttg tcagtgcttc gcttttgacc cgtttctaca 420
attaccttgt agagattggt gctcttgact caacaataag gttgtcagtc gatcttacct 480
gtaaatttgt tagaacggta ctcccatcgt ctaacactgt acacaaaact tgtcttggtc 540
tgtattattc agcccagaca ctttttgttt ctttagcacc attccttatg ttaccagctg 600
tagttagtct gcttaattca ggctatacaa ttggcacata tttgtatgca aaaactggct 660
ggccttgtaa ttacaatgcc acgcaacacc ttgattataa ttcttactgt gcaggtgact 720
tggtttgtca agcctgtttt gacggtcaag actccctaca tttgtatccg catttacgtg 780
ttaatcagca gcctcttcag accactgact acactgttta tgcgctttca ctaatactac 840
tattagctaa catgactctt gtcatgggta cgctaatagt tactttcttt gtgaacttct 900
atggtgtgca aataccattt tatggtacac ttctgataga ttatcagtcc gcgctgatga 960
tgactttctc agtgtactac ttttataagg taatgaagtt tttccgccat ctcacacatg 1020
gatgtaaaat tccaacgtgt atggtatgtg ctaaacttcg taccccacct actataacag 1080
ttgagactgt cgttcaaggc aggaaatacc catctgttat tgaaacaaat ggcgggttta 1140
caatttgtaa agaacacaac ttctattgca aagactgctc tctacaaaca cccggcactt 1200
tcatcccgac agaagctatt gagtcgctct cacgagctac caggcttagt gtcaaaccaa 1260
cagcaccagc attcttactt gctagagatg ttgagtgcca aactgatgtt gtcgttgctc 1320
gcgcaatgca taaccaaaat gcgcatgtgt gcatttcaaa atactctgat atccgtaccg 1380
ttgaccaact acttaagcct actccactgt tttcatacac tcccgatgtt atcatcgcgg 1440
cagactttga caacagaggt agtcttaaga cagctaaaga attagctgtg gttttgtcaa 1500
tggaccttaa acgtactata attatcattg atcaggctta ttctagaccc attgataatt 1560
atcaggaagt tgcttctcgt attgagaagt attacccagt tgcaaagatt acacccacag 1620
gtgacatctt tacagacatt aagcaagcga ccaatggcca agctagtgac tctgctatta 1680
atgcagctgt tctggctgtc cagcgcggtc ttgattttac aatcgacaac cctaacaata 1740
tattaccaca ttacgccttt gacttttcaa cccttaatgc agaagaccag tctaccattt 1800
tggagagtgg ttgtgctaaa ggcaatctca agggcactaa tgttggtgtt gttctttcag 1860
ctagccttgt tacacgtctt agtcagcagg ctatatgtgt gattgctaat gctgcttcac 1920
gtaatggtgt aacatgcgct gttactccat ctacacttgt tatgcgtggg aatattgcaa 1980
cacagccctt gactcgcatc aaagctggtg cacctcccat gcgtcaaaaa attttatgtg 2040
ttatcctggc acttgctatt gtgtactttg ctgctatggc ttttggcttt tttgcaagtc 2100
aaattacgct taatacagtg cctacgatta aatctgatat ccgcgcctct accttctacg 2160
ttgttagaga tggagtcttg gatactgttc gctcaaatga caagtgcttt gcaaataagt 2220
ttttggcatt tgatagcttc attcaagcac cttacactaa ttcacctgac tgtccagtcg 2280
ttgtgggagt tgttgaagta acgacgcact ctattcctgg aattccagca ggtgtcattc 2340
atagagacgg tctcatactt aacatttatg aacagtctct ttatgaaatc catcagcgtc 2400
agtctatggt tagggatgcg ttgtcactca agacagcaaa tctctttaac ctaggcaagc 2460
gtgttgtagt aggatacact caacatgaag ttgttgtggg tacctcctat tttaattctc 2520
ctgcactttt taacgcaaag tgcaccttct tacagtacca ggacactaga caactctatt 2580
gctatgatac tgttcctact gaacataagc tttactctga tgtgcttccg cacgtcgagt 2640
ataaggctat tgacattaat ggtgatcttg ttcctttcaa gataccggag cagataatgt 2700
tctatccaca tattgtgcgc tatactagca attcctattg ccgtatgggg cattgtttta 2760
atactaaccc tggtatttgc atttcattta cggacgaatt tccgtatagt gaaaatgtta 2820
aacccggtgt atactgtgct gatacctctt tgcagttgtt ttcaaacctc gttttgggca 2880
ctgtatctgg tattcacatc tttacatcaa cagctgcatt gcttggatct actattgtga 2940
tcatactatg cgttgttgct gttcttgcag ttcagcgatt cttcaaggag tacacaactt 3000
ttgttatgta cacttgtggt cttgctcttg tcaacattgt gggcattgca cttatataca 3060
agtgccttgt cttcgcgatc ttctattatg caatctacct ttactttgtc cttactttcc 3120
cctcctttaa gaggaatgtg gcattgtttt acttcgctgt agtgatcgtg ccgcacgtga 3180
gtaacatgca attgcttgcg ctcattgtgt gtagcattat ctactttctc tacacctatg 3240
ttcatactgt agctaagaca gctgggaaat tctcttcctt cttagacgca gctaaagcta 3300
cttttgtcat tgacaatgaa aagtacgtgt tgcttaaaga cctcgctggt gctgaatttg 3360
accagtatct ggcctcttac aacaagtaca aatatttttc tggtactgct tctgataagg 3420
attatgataa ggtctgtatg gcatttcttg ccaaggcttt gtcatctttt cgtgaaggag 3480
gcggttcaca gttgtacaca ccacctaaat ttgcagttgt tcagagtctt aagaccaagc 3540
tgcaagcagg tatcaaaatc ctcctgcacc cttcaggtgt agttgagcga tgtatggtct 3600
cagttgtcta caatggatct gcattgaatg gcatctggct taagaatgtt gtctactgcc 3660
cacgccatgt aattggaaaa ttccgtggtg accagtggac tcacatggtc tcaattgctg 3720
attgccgcga ctttatagtc aagtgtccaa tacagggtat tcagctaaat gtccaatcag 3780
ttaagatggt aggagctctc ctccagttaa ctgttcatac caacaacaca gccactccag 3840
actataagtt tgaaaggctc caaccaggat catcgatgac aattgcttgt gcttatgatg 3900
gcattgtacg gcatgtctat cacgtggtcc tccaacttaa taatcttatt tatgcaagct 3960
tccttaacgg agcttgtggt agtgtgggtt acactcttaa gggtaaaaca ctctacttac 4020
attacatgca ccacattgag tttaacaaca aaactcatag tggtacagat cttgaaggta 4080
acttctatgg cccctatgtg gatgaggaag ttattcagca acaaacagca ttccagtatt 4140
acactgataa tgttgttgct caattatatg cacacttact gactgttgat gctagaccaa 4200
aatggctggc acaatctcag ataagtatcg aggattttaa ctcatgggct gctaacaatt 4260
cctttgctaa cttcccatgt gaacaaacta atatgtccta cattatggga ctctcgcaaa 4320
ctgctcgagt ccctgtagaa cgtatcctca ataccattat acagctaacc accaatagag 4380
atggtgcttg tattatggga tcttatgatt tcgagtgtga ttggacgcca gagatggtat 4440
acaatcaggc tccaatttca ttgcagtcag gagtagttaa gaaaacttgt acgtggttct 4500
tccacttctt gtttatggct attaccatgc tactcgctgc catgcatgtt ttccctgtac 4560
acctgtaccc aatagtactg ccatgcttca ttgtcgtggc attcctgttg actttaacca 4620
ttaaacacac tgttgtgttt accactacat atttgcttcc gtcacttttg atgatggttg 4680
taaatgctaa cactttttgg ataccgaaca catttctgcg cacctgctac gaaactatat 4740
ttggttcccc aattgctcag cgactgtatg gttacactgt tgctttttat atgctgatct 4800
atgctggact tgcaatcaac tatacgttga aaacactccg gtatagagca acttcattct 4860
tatctttttg catgcagtgg tttcaatatg gttatgttgc acacattgcg tacaaactgc 4920
ttaataaacc ctggacagaa tcactactct tcacagcctt cacaatgcta accagtcatc 4980
ctttgttggc tgctcttagc tggtggctag ctggtcgcgt aactctgccc attatcatgc 5040
ctgacttagc tattcgtgtt ttggcgtata acgtcattgg ctatgtcata tgtgttcgat 5100
ttggccttat gtggcttgca aatcgattca caac 5134
<210> 5
<211> 5500
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 5
cttgcaaatc gattcacaac tgtacctatg ggcacatacc agtatatggt gtctgtagag 60
caacttaagt acatgatggc agttaagatg tccccaccgc gtaatgcgtt tgaggtgctt 120
atagccaaca ttagacttct tggtttgggt ggaaaccgta acattgctgt ttctactgtc 180
caaaacaaaa ttcttgatgc aaaagctact gctgttgttg ttgctaacct tcttgaaaag 240
gctggcgtca caaacaagca cgctatttgc aaaaagattg tgaaactcca caatgatacc 300
cttaaagcca ccacttatga ggaggttgag gtagcacttg tgaaacttct ttctcacata 360
attgagttct tgccaactga tcaggtagat gcttatctag ctgatgcggc caatgctcaa 420
catgttaata cctatttcga caacttgctt gagaacaaag ctgttgttca ggctgttgcc 480
gatatcaaca ttaatctgga ttcttataga atttataagg aggcagatgc tatttacaaa 540
cgatctgttg agatgaacga atctccacag gagcaaaaga aaaagcttaa agctgttaac 600
attgcaaagg cggaatggga gcgtgaggct gcttctcagc gtaagcttga aaagcttgct 660
gatgctgcta tgaagtctat gtatcttgca gaacgtgctg aggatcgtcg cattaagcta 720
acctctggac ttactgcaat gctttaccat atgcttagac gtcttgactc agatagggta 780
aaagctctgt ttgagtgcgc taaggcacaa atcttgccaa tacatgctgt agttggaatt 840
tctaatgaca accttaaagt tatttttaac gataaggata gctactctca ttatgtagag 900
ggcaacacac ttatacataa gggagttcgc tacactattg tgaagaaact ctccttagat 960
aatgcaccta ttgaaggcgt accagaagaa ttccctgtgg tcgttgagac tgttagggaa 1020
ggtgtgcccc agttgcaaaa caatgagcta tgtttgcgca atgttttcac tgctcagaac 1080
acagctcagg acttcaatgg caatgaatcc actgtaaaat ctttttatgt tactagagcc 1140
ggtaagaaga ttttggttgc cattacatca actaaagaca atcttaagac tgtgacctgc 1200
cttactgaga ccggtaagac agtccttaac ttggaccctc ctatgcgctt cgcacatacc 1260
gtaggtggaa aacagtctgt tgtctatctc tattttattc agaatattag ttcactcaac 1320
agaggtatgg ttattggcca catctctgaa actactatcc ttcaggcaag tggcactcaa 1380
attgagtacc agcaaaatgc ctctcttttg acctatttgg ctttcgctgt agaccctaag 1440
acagcctacc ttaagcatct tgctgatggt gggtctccta tacagggttg tattcagatg 1500
attgctacta tgggtcctgg atttgcagtt actactaaac cacaacctaa tgagcatcag 1560
tattcttatg gtggtgcttc aatttgtctt tattgccgtg ctcatatacc acatcctggt 1620
gttgatggac ggtgccccta caaaggccgc tttgttcaca tcgacaaaga taaggaacct 1680
gtttccttcg ccttgactca tgagccatgc agttcttgtc aacggtgggt caattatgac 1740
tgcacctgtg gatctagtct gcagaattcg gcttatttaa acgagtaacg ggttctagtg 1800
acgcccggct agaacccctg cagcctggaa ctcaaccaga tgctgtaaaa agggccttcc 1860
atgtgcataa tgataccacc tctggtatat tcttaagcac aaaatctaac tgcgctcggt 1920
ttaaaaccac acgcagtgcc ctgcctttac ctaacaaggg agaggttgaa ttgtactttg 1980
ttactaagca gtgtgcagct aaagtcttcg aaatcgagga ggaatgctac aacgctctta 2040
gtacagagtt ttatactact gatgatacat ttggtgtcct tgccaaaact gagttcttca 2100
agtttgacaa gatacctaat gtcaatcgcc agtatctgac taaatataca ctcctggact 2160
tggcttatgc tctacgccat ttgtcaacat ctaaggatgt tattcaagaa attttgatca 2220
ccatgtgcgg aacccctgaa gattggtttg gagaaaattg gtttgatcca attgagaatc 2280
catcctttta caaggagttc cataaacttg gagatattct taaccgttgt gttcttaatg 2340
ccaataagtt tgctagtgcc tgtatagacg ctggtcttgt tggcatatta acacccgaca 2400
atcaagacct cctgggtcag atctatgact ttggagattt tattattaca caaccaggta 2460
atggatgtgt ggacttagca tcctattatt cttatttaat gcccattatg tccatgactc 2520
acatgttaaa gtgtgagtgt atggatagtg atggcaaccc acttgagtat gatggatttc 2580
agtatgactt cacggacttc aagcttggct tgttcgagaa gtattttaag tactgggacc 2640
gtccttacca tcctaacact gttgaatgtc cagatgaccg ttgcgtattg cactgtgcga 2700
acttcaatgt gttgtttgct atgtgtatac ctaatacggc atttggcaat ctttgttcaa 2760
gagctactgt tgatggccac cttgtggtcc agacagtggg tgtacacttg aaagaacttg 2820
gtatagtcct taacgaggac gttaccacac acatggcaaa tattaatcta aacactctat 2880
tgcgattggt tggtgatccc accaccattg caagtgtctc agacaagtgt gtagatttaa 2940
gaactccttg tcagaccttg gctactatgt ctagcggaat tgctaaacag tcagtcaagc 3000
ccgggcattt taatcaacac ttctacaagt atttgcttga tagtaaccta ttagaccaac 3060
ttggaataga cattcgccac ttctactata tgcaggatgg tgaagcggct atcacagact 3120
acagctacta caggtataat acccccacga tggtagatat caagatgttc ttattttgcc 3180
ttgaggtggc agataagtat cttgagccct acgaaggtgg atgtattaat gcacagtcag 3240
ttgtggtctc taatttggac aagtcagcgg gctacccctt taacaagcta ggtaaggctc 3300
gtaactatta cgacatgact catgccgagc aaaatcaact gtttgagtat acaaaacgca 3360
atgttttgcc tacactcact cagatgaacc ttaagtatgc aatttcagcc aaggatcgtg 3420
ctcgcactgt ggcaggagtg tctataatta gcaccatgac taacaggcag taccatcaaa 3480
agatgctgaa atctatttca cttgcacgca atcagaccat cgtgattgga acaaccaaat 3540
tctatggtgg ttgggacaac atgttacgac gactgatgtg taatatcaac aatcccattt 3600
tagtgggttg ggattaccct aagtgtgatc gttctatgcc aaacatgctg cgcattgctg 3660
cttcgtgctt gctagcacga aaacacactt gttgtaacca aagccagcga ttctaccgtt 3720
tggctaatga atgttgccaa gtactatctg aagtggtagt ctctggtaac aacctctatg 3780
taaaaccagg tggcactagc agtggtgatg cgaccacagc ttatgccaat tcggtattta 3840
acatcttaca ggtggtttct gctaatgtag ccaccttctt atcaacttcc accacgacac 3900
atcttaataa ggacattgct gacttgcatc gtagtcttta tgaagatatt tatcgtggtg 3960
actctaatga tatcaccgtc atcaatagat tctaccagca tctccaaagt tactttggac 4020
ttatgatatt gtctgatgat ggtgttgcat gcatagactc agccgttgca aaggctggag 4080
ctgttgctga tcttgatggt ttccgagaca ttttgtttta ccaaaacaat gtttacatgg 4140
cagactcaaa gtgttggaca gaaactgaca tgaatgttgg ccctcatgaa ttttgctcac 4200
agcatactgt gttagcagag catgatggta aaccttacta cttaccttac ccagatgtct 4260
cgcgcattct gggtgcatgc atctttgtgg atgacgttaa caaggctgac cccgttcaga 4320
accttgaacg ttacatctca cttgcaattg atgcatatcc cctcaccaag gttgacccta 4380
ttaagggtaa agtcttttat ttgttactag actacatacg tgttcttgct caggagttac 4440
aggatggtat ccttgatgct ttccaatcac tcactgacat gtcgtatgta aataacttta 4500
tgaatgaggc cttttatgct cagatgtatg agcaaagtcc tacactacag gccagcggtg 4560
tttgtgtggt gtgtaactca cccactatac tgcgctgtgg tgattgcatt cgtcgaccac 4620
tactttgttg cgtctgtgcc taccagcatg ttacgcagac tacacataaa cgtatcattg 4680
ctatcaacaa ctacatttgt agtgttgaga attgcaatga ggacaatgtt gaaaaacttt 4740
tcatttctgg cactgcaatt tattgtgaga atcacaaacc cacgctgtgc atacccattg 4800
tagctaatgg ttctgttttt ggtatctatc gccacactgc ccgtggtagt gatgacatag 4860
acctctttaa cgagcttgct acatctaact atgacactat tgaaccttat cagaaggcca 4920
atcgtgcacc tttatcactt atgctcttcg ctgctgaaac cattaaggca ctcgaggagt 4980
ctatcaagaa gtcatatgct accgcaaccg tcaaggatgt gtatgaccaa cgcttcatta 5040
aacttctatg ggaacagggt aaaaagccgc cacccataac gaagaaccac attttcactg 5100
gctaccattt taacaagaat ggaaaaaccc aagttggtga ttacattctt gctaaaacag 5160
atggcagtga cacttatact tacagaggaa catctaccta caaactccaa acaggtgatg 5220
ttctagtctt aatggcacat gttgttacac cgctctcagc accccctgtg ctaacgcaga 5280
caacatatgt cagaaaatca cttttacccg actctgttgg tgcgtcttat tatgtgcaac 5340
attttaagtc atataatgag atagctatgc agagggttac aacagtatta ggtccgccag 5400
gcacaggtaa gtcaaccttt gctattggtt tggctaagta ctttcctagt gcacgtattt 5460
gctacactgc gtcttcgcat gcagcaatag atgcactctg 5500
<210> 6
<211> 4343
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 6
gcagcaatag atgcactctg tgaaaaagct ttcaagacaa tacctgtagg ccaatgcagt 60
cgtatcgtac ccacacgtac aactgttgag tgctttcagg agtttgtcgt aaataacaca 120
actgcacagt atatcttctc gactatcaat gccttacctg acattaagtg tgacattgta 180
gttgtagatg aggtttctat gttgaccaat tatgagcttt cctctgtgaa tgctcgtttg 240
gtttacaatc acattgtgta tgttggtgat ccttatcagt taccttcacc tagaactatg 300
cttacgtctg gccagctttc gccagctgac tataacgtag ttactgatat aatggtacat 360
gcaggagcgg acgttatgct cgacatgtgc tacagatgcc cacgtgaaat cgttgagaca 420
gtgtctaaac ttgtctacga taacaaacta aaagcggcga aaccgaactc aagacagtgt 480
tacaagacca ttgtgaactt tggtcctgga gacgttgctc atgagggaca atctgcctac 540
aacgaagcac agttgcgttt cgcactcgca tttagacaac aaaagcggtg ggataacgtg 600
actttcatat ctccatataa tgctatgaat gtgaaagcat ccttagcagg tttctctact 660
cagaccgttg actcttctca aggttctgag tatgattatg ttatcttttg cgtgaccact 720
gactcagcac acgcacttaa catggctcgt ttgaacgttg cccttacacg cgcaaagata 780
ggtatccttg tggtgtttag gcaggcaaac gaactttaca atagtttgca gtttgaatct 840
attgattcac agcttcagtc gagtgctgag aaaaacctca caccactgtt taagcgctgc 900
ggctatgagt ataatggcgt ccatccagct catgctttga cctggcatga ttgtggtgca 960
gagtaccgct gtgaggagcc acttgctaaa ttagtaggag ttgccgatgg cactcttata 1020
tcatataaaa ccctagtatc cacacttggg tttcttccat cacttaaaat tgatgcatat 1080
cataatatgt tcctaacacg tgacgcgtgt cgcacctatg ttcagagttg gatcggcata 1140
gacgttgaag cagcacacgc cataaaacct aacaccggga ctaacctgcc attgcaaata 1200
ggttttagta ccggaaagaa tttttcagtt actccagagg gaatttgggt aaacgagcac 1260
ggatcttgca ctgagcccgt ccctgccaaa atacctcctg gagaacaatt tcgtcacctt 1320
aagaaggaca tgcgccaggc gcgtccttgg aaggttgttc gacgtgagat tgctactcac 1380
attgctgagg tagctcctca cactgattat atatgctttg tcacttgggc tcaccagctt 1440
gagctagcga caatgcgcta ctttgtcaaa ctaggtatgg aagagaaatg cttttgtggc 1500
aggcgggctt gtttcactaa tggaactgag ttcgcttgca aagcacacca ttctctcacc 1560
attccacaat gtgattatgt gtacaatcca ttcctcatcg acgtggctac gtggggattc 1620
tcgggacggc tttccaccaa ccatgacgcg gtatgcacat atcatgctaa tgcccatgtt 1680
gcatcagctg atgcaatcat gacggtatgt ttagctatcc atgaactgtt cagtactgtt 1740
gactggaacc ttgaatttcc agtaactgct gagcaatcac aacttaacaa ggcctgtcgc 1800
ttagtacagg caaattattt aaatatacta ctcactacaa ccaaagccac ggtggttcat 1860
gatattggta acccaaaagg tatccctatc gtgcgcaaac ctggtgttaa atatcacttc 1920
tatgatcaag cacccattgt caaacacgtt caaaaactaa agtacaagcc agagatggag 1980
gcccgtttca ccgatggttt gactatgttt tggaattgta atgttgacac ataccctgct 2040
aatgcccttg tgtgccgcta cgatactcat cggcagaagc atttaattgg acctaatggt 2100
tcagcattat atgttaataa gcatgctttt ctcacccctg agatgcatac ttatgctaca 2160
cataaactca acttggctcc actcatctac tactccacca cagattgtag tagtgaacag 2220
cctattgttg ttacctacag agattgtgtc acccggtgca atactggaaa aactctctgt 2280
ccaaatcatg ctcttgaata ccaagagttt atcaatgcat acaatctcat ggctcgccat 2340
ggatttaatg tttacatacc acgcaatgtc aacgtctata actgttggct tactttcact 2400
aatctccaaa accttgaaaa cttagcttac aactgttatt ataagaactg caatgctcac 2460
gttgatgggc agcttgatgt agttattaat aataacgctg tatatgctaa ggtcgacaat 2520
aatcttgtca aactctttga caatcgcact aacttacctg tctcagtggc ctttgaacat 2580
tacactaaca ggcatacccg ttcactgcca actacacagc tgttatctgg tttaggcgta 2640
actgccacca gaaatttcac tgtgtggttc gacaatgata caattttcca atacactatt 2700
aatgtatcta cttatactga catcgaccct agtacccatg ttgtcctctg tgatgatagg 2760
tacggaacag attggagtca gtttaaccaa cttcctaatg cagtgttcct caccaaaact 2820
aaggtgaaga aaacagaacc gtttgtttgt acagcactga ccctaaatgg cctcgccatt 2880
gacggtgaag agctatacat ctatgtacgc tataacaatc aactgaccac atttgctact 2940
acttgtacac agggtagaaa tgttgagcag tttataccta aaacacctat ggaaagagac 3000
ttccttgaga tgtctcaaca gtccttcatt gaacaatatc aattgcagga actgggtgtt 3060
gaacacatta tctatggtga tgattccagt ccagtcattg gcggaactca cacacttatc 3120
tcactagtta aaaacaagtt tgaacatcag cttgtcaacc atgtttacaa cccagtccag 3180
aactgtgttg ttacctcacc taacgcaagc tccaagaacg tttgcactgt tcttgatgtt 3240
cttcttgatg actacattga catcataaga caagcacatg ccagttacac aagtaaatct 3300
aaagtattca ctgtgtcaat tgacaaccaa caaattagat tcatgctctg gcatgatgag 3360
caagtcaaga cttgctaccc aatcttacag tcacttacca atggttacca gatgccatct 3420
gtgtacaaaa cattggttac tgacttacaa ccagctgaca tccctaatta tcattcctac 3480
accccccggg tgcctggagt agttaagaat gttatcaagt accgccaact tttcaactac 3540
atagttaaaa aggataggtt ggcagtacca cacaatatga ctgtattaca ccttggagct 3600
gcatctgcac taggtacagc accaggttct tcagtcataa aacaaatgtt tcctgaagga 3660
actgttctta ttgaccttga tataagagag ttcacttcag atgctaacca aataatagtt 3720
acagactaca gaacttacat accaccacac cacgtagacg tcatattttc tgacctctac 3780
tgttgtgatg acatacactt ctttgacaat ctaataagga tagttaagga gaggctcgcc 3840
ctcggtggtt ctatctttgt taagataact gaacattcat tctcacccga actctactca 3900
cttgcggggt ggttcgatga ttatcaacta ttttgcacag cagtcaatgc ctcgtcttca 3960
gaagcatttt tatgctgttt taattatttg gggcaagcta aggaaaacat taatggtttt 4020
aacttacatg cttcctacat tcaatggcgc aatgaaatag cattgacacc aacctattct 4080
cctttagcgg ataacccggc tacggcctgt aagctaaaag caacgcctat tatctcggct 4140
cgtgagttag agaagaagcc tattcttcgc tatctcgttg catcaggacg ccttcttgtg 4200
aggccaccag aatgcagaga gctctattga ttatgacctt actttgtctc gttcgagcaa 4260
agtttgctga tgatctactc gatttactca cctttccggg tgcacatcgc ttcttacata 4320
aacccacgag gaattccagc agt 4343
<210> 7
<211> 3968
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 7
ccacgaggaa ttccagcagt ctctactcgc gggctaataa ttttgatgtt ggcgttcttc 60
ctggctaccc cactaagaac gttaacctct tctcaccact tactaactcc actttgccca 120
ttaatggcct tcatcggagt tatcaaccac tcatgctgaa ttgtcttact aaaataacta 180
accacactct cagcatgtat ctccaaccta gtgatataca aacctatagc tgcggcggtg 240
ccatggttaa acaccagaca catgatgcag ttcgtatcat tttagacctc actgccactg 300
accacatctc tgttgaagtc gttggccagc atggtgaaaa ttatgtgttt gtttgtagtg 360
agcagtttaa ctataccact gcattacaca actctaccgt cttctcactt aattctgagc 420
tttattgctt tactaataac acctacttag gtattcttcc acctgattta actgacttta 480
cggtctatcg tactggtcag ttctatgcta atggttacct tttaggtact ttacctatta 540
cggttaacta tgttaggttg tatcggggtc acttggcggc caatagtgcc cactttgccc 600
ttgcaaactt aaccgataca cttataacac ttaccaatac tactatatcg caaatcactt 660
attgtgataa gtcagtagtt gattcaatag catgccagcg ctcttctcac gaagtggagg 720
atgggtttta ctctgaccct aaatctgccg ttagagctag gcaacgtact attgttacac 780
tacctaagct ccctgagctt gaagtagtgc agttaaatat ttctgcacac atggattttg 840
gcgaagccag acttgacagc gttaccatta atggtaacac atcctactgt gtcactaagc 900
cttacttcag gcttgaaact aactttatgt gtacaggttg cactatgaat ctgcgcactg 960
atacctgtag ttttgacctg tcagcagtaa acaatggcat gtcattctct caattctgtc 1020
taagcactga atctggtgct tgtgagatga aaattattgt tacctacgta tggaattact 1080
tgctaaggca gcgtttgtat gttacagctg tagagggtca gactcacact ggaaccactt 1140
cagtacatgc aacagacact tctagtgtaa tcactgatgt ctgcactgac tacactatct 1200
atggagtctc tggcactggc attattaagc catcagatct cttattgcac aatggcatag 1260
cattcacctc tccaacaggt gagctttatg catttaaaaa tataaccact ggcaaaaccc 1320
ttcaggtctt accgtgtaaa accccttctc tactgattgt gataaacaac accgttgtcg 1380
gtgctatcac atccagtaat tcaactgaaa ataataggtt tactactact attgtcacac 1440
ctactttctt ttattccaca aatgccacca ccttcaactg caccaagcct gttttgtcct 1500
atggacccat cagcgtgtgt agtgatggtg caattgcggg aacatccaca ttacagaata 1560
ctcgaccatc catagtttca ctatacgatg gcgaagttga aataccatct gcattttctc 1620
tttctgttca gacggagtat ttgcaagttc aatcagagca agttatagtt gattgtcctc 1680
agtatgtatg caatggcaac agccgttgtc tacaattact ggcacaatac acctcagctt 1740
gctctaacat tgaagcagct ctgcattcct ctgtacagtt ggatagcaga gagattataa 1800
atatgtttaa aacatcaaca cagtccttgc agttggctaa tattaccaac ttcaagggtg 1860
actacaattt tagcagcata ctaaccacca gacttggtgg cagatctgct attgaagacc 1920
ttctttttaa taaagttgtt actagtggcc ttggcactgt tgatcaggac tacaaagcct 1980
gctctagaga catggccatc gctgacttag tttgttccca gtattacaat ggcatcatgg 2040
ttctacctgg tgttgttgat gctgagaaaa tggcaatgta tactggctct cttactggag 2100
ctatggtatt tgggggactg actgctgcag cggcaatacc attcgccacg gcagtacaag 2160
cccgccttaa ttatgtcgca ctgcaaacaa atgtactaca agaaaaccag aaaattcttg 2220
cagaatcatt taaccaagca gttggcaata tatcacttgc actatcctct gttaatgatg 2280
ccatcaagca aacttctgag gctcttaaca ccgtagctat tgctattaaa aagattcaaa 2340
cagttgttaa ccagcagggt gaggcattat cacacctgac tgcacagctg tcaaacaatt 2400
ttcaggcaat ttcgacttct attcaagaca tttacaaccg tcttgaggaa gtagaggcta 2460
accagcaagt tgaccgtctc atcacaggac ggttggctgc acttaatgca tatgttactc 2520
agttactcaa tcagatgtct cagattagac aatctcgatt gctagctcag caaaagatta 2580
atgagtgtgt caaatctcag tcgtccagat acggtttctg tggaaatggc acacacatct 2640
tctcacttac acagactgca ccaaatggca tatttttcat gcatgcagtg cttgtaccca 2700
acaaattcac acgtgtcaac gcttctgccg gcatttgtgt ggataatacc agaggctact 2760
cattgcagcc tcaacttata ctctaccagt ttaataactc ctggagagtt acacctagaa 2820
atatgtatga acccagactg ccccggcaag ctgattttat acaattaact gattgcagcg 2880
ttacttttta caacaccaca gctgctaatc ttcccaatat tattcctgac gttatagatg 2940
ttaatcaaac agtcagtgat attattgaca atctacctac agcaacacct cctcagtggg 3000
atgttggtat ctataataat actattctca accttaccgt tgagattaat gatctacaag 3060
agcggtctaa aaacctctct cagattgcag atcgtttaca aaattatatt gataatctta 3120
ataatactct agttgacctt gattggctca acagagtgga aacttacctt aaatggccgt 3180
ggtatatatg gcttgccatt gccctggctc ttattgcatt tgtgacaatc ctcataacaa 3240
tctttctttg tactggttgt tgtggtggtt gctttggttg ttgtggcggt tgttttggcc 3300
ttttctctaa gaagaaaagg tataccgacg accaaccaac accgtccttt aagtttaagg 3360
aatggtagtc gatgactggg ccgttaccat ccctggacaa tatattattg ctatactagt 3420
tgtcacctgc attggtgtgg cactactttt tattaacact tgcttagctt gtgttaaatt 3480
attttacaag tgctacctag gggcagcata tcttgttagg cctattatag tgtactactc 3540
caagccgaac cccgtacctg aggatgagtt tgtaaaagta caccaatttc ctagaaacac 3600
tcactatgtc tgacgcagaa gagtggcaaa ttattgtttt cattgcgatc atatgggcac 3660
ttggcgtcat cctccaagga ggctatgcca cgcgtaatcg tgtgatctat gttattaaac 3720
ttattctgct ttggctgctc caacccttca ccctagtggt gaccatttgg accgcagttg 3780
acagatcatc taagaaggac gcagttttca ttgtgtccat aatttttgcc gtactgacct 3840
tcatatcctg ggccaagtac tggtatgact caattcgttt attaatgaaa accagatctg 3900
catgggcact ctcacctgag agtagactcc ttgcagggat tatggatcca atgggtacat 3960
ggaggtgc 3968
<210> 8
<211> 635
<212> DNA
<213> Porcine delta coronavirus (Porcine deltacoronavirus)
<400> 8
ggcgtgcact tgacattgat tattgactag ttattaatag taatcaatta cggggtcatt 60
agttcatagc ccatatatgg agttccgcgt tacataactt acggtaaatg gcccgcctgg 120
ctgaccgccc aacgaccccc gcccattgac gtcaataatg acgtatgttc ccatagtaac 180
gccaataggg actttccatt gacgtcaatg ggtggagtat ttacggtaaa ctgcccactt 240
ggcagtacat caagtgtatc atatgccaag tacgccccct attgacgtca atgacggtaa 300
atggcccgcc tggcattatg cccagtacat gaccttatgg gactttccta cttggcagta 360
catctacgta ttagtcatcg ctattaccat ggtgatgcgg ttttggcagt acatcaatgg 420
gcgtggatag cggtttgact cacggggatt tccaagtctc caccccattg acgtcaatgg 480
gagtttgttt tggcaccaaa atcaacggga ctttccaaaa tgtcgtaaca actccgcccc 540
attgacgcaa atgggcggta ggcgtgtacg gtgggaggtc tatataagca gagctcgttt 600
agtgaaccgt acatggggac taaagataaa aatta 635
<210> 9
<211> 366
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 9
atagggggga tggagcaaaa aaaaaaaaaa aaaaaaaaaa aaagggtcgg catggcatct 60
ccacctcctc gcggtccgac ctgggcatcc gaaggaggac gcacgtccac tcggatggct 120
aagggagagc cactgtgcct tctagttgcc agccatctgt tgtttgcccc tcccccgtgc 180
cttccttgac cctggaaggt gccactccca ctgtcctttc ctaataaaat gaggaaattg 240
catcgcattg tctgagtagg tgtcattcta ttctgggggg tggggtgggg caggacagca 300
agggggagga ttgggaagac aatagcaggc atgctgggga tgcggtgggc tctatggaag 360
cttctc 366
<210> 10
<211> 3390
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 10
ggcgtgcact tgacattgat tattgactag ttattaatag taatcaatta cggggtcatt 60
agttcatagc ccatatatgg agttccgcgt tacataactt acggtaaatg gcccgcctgg 120
ctgaccgccc aacgaccccc gcccattgac gtcaataatg acgtatgttc ccatagtaac 180
gccaataggg actttccatt gacgtcaatg ggtggagtat ttacggtaaa ctgcccactt 240
ggcagtacat caagtgtatc atatgccaag tacgccccct attgacgtca atgacggtaa 300
atggcccgcc tggcattatg cccagtacat gaccttatgg gactttccta cttggcagta 360
catctacgta ttagtcatcg ctattaccat ggtgatgcgg ttttggcagt acatcaatgg 420
gcgtggatag cggtttgact cacggggatt tccaagtctc caccccattg acgtcaatgg 480
gagtttgttt tggcaccaaa atcaacggga ctttccaaaa tgtcgtaaca actccgcccc 540
attgacgcaa atgggcggta ggcgtgtacg gtgggaggtc tatataagca gagctcgttt 600
agtgaaccgt acatggggac taaagataaa aattatagca ttagtctata attttatctc 660
cctagcttcg ctagttctct accgacacca atccaggtgc gtctgccacc aagttggcta 720
ccctttctag gggcgctttt gcgcttgctc accattagat tacctggaaa ccagccattc 780
aggttggagt ttccccaggc acttttgcgt gggcattagc ggcttgtggt ttttgcacaa 840
aatctaagct acttaccgtt cctctgacca ttcaccactt ctatagacag cactgactac 900
cgtagggttc aagtcacacc ggtctgcacc gcccgtcagc ggacacatta cccagcatag 960
cactccttgc accgagccta ggtagcttgc agggattatg gatccaatgg gtacatggag 1020
gtgcattccc atcgaccaca tggctccaat tctcacacca gtcgttaagc atggcaagct 1080
caagctacat gggcaagagc tggccaatgg catatcagtc agaaatccgc cacaggatat 1140
ggtgatagtg tcaccaagtg acacctttca ctacactttt aagaaacctg tggaatcaaa 1200
caacgatcca gaattcgctg ttctgatata ccagggtgac cgcgcttcaa acgctggact 1260
tcacaccata accacttcaa aggccggtga cgctcgcctg tataagtata tgtaatgtgc 1320
aactgccacc tgcagctgcg agatttatat agattgtgca ataagcggca catcagaaga 1380
gaggatgttc ctgagcttat tgaccctctc gttaaaactc gctgttttgc ttacagtctc 1440
gtggttcttg ctaatgctaa tccaattgca tttagcatac tacctcggaa acttcttatc 1500
aatggtgagc ctttactgct tgaatatggt agcatatatg gtaaagactt tatcattcga 1560
ccatcgctcc aagtcattct tgaagatgaa ttaaattaaa gttttgacac caatctatca 1620
tggctgcacc agtagtccct actactgacg cgtcttggtt tcaggtgctc aaagctcaaa 1680
acaaaaaagc cattcatcct cagtttcgtg gcaatggagt tccgcttaac tccgccatca 1740
aacccgttga aaatcatggc tactggctgc gttacaccag acaaaagcca ggtggtactc 1800
cgattcctcc atcctatgcc ttttattata ctggcacagg tcccagagga aatcttaagt 1860
atggtgaact ccctcctaat gataccccag caaccactcg tgttacttgg gttaagggtt 1920
cgggagctga cacttctatt aagcctcatg ttgccaaacg caaccccaac aatcctaaac 1980
atcagctgct acctctccga ttcccaaccg gagatggccc agctcaaggt ttcagagttg 2040
accccttcaa cgctagagga agacctcagg agcgtggagg tggcccaaga tctcaatctg 2100
ttaactccag aggcacaggc aatcagccta ggaaacgcga ccaatctgca cccgctgcgg 2160
tacgtcgtaa gacccaacat caagctccca agcggacttt acctaagggt aaaaccattt 2220
ctcaggtatt tggcaaccgg tctcgtactg gtgccaatgt cggctctgca gacactgaga 2280
agacgggtat ggctgatcct cgcatcatgg ctctagccag acatgtgcct ggtgttcagg 2340
aaatgctttt cgctggtcac ctcgagagca actttcaggc gggggcaatt acccttacct 2400
tctcttactc aatcacagtc aaggagggtt ctcctgacta tgagagactt aaggatgcgc 2460
tcaacacggt cgttaaccag acctatgagc cacccaccaa accaactaag gacaagaagc 2520
ctgacaaaca agaccagtct gctaaatcca aacagcagaa gaaacctaaa aaggtaactc 2580
tgccagcaga caaacaggat tgggagtggg atgatgcttt tgagataaag caggaatcag 2640
cagcgtagac atcaatctat gtctgttaaa cccacccaac tccactcaaa tatctctttg 2700
gttccagaga gtcgtagtgt atagccagag agccagtcag agggcgctat catgcaaact 2760
agggctggct actctagcac agaatcacat cccgataatc aacagtgcta gaaggttgat 2820
tataccattt aatatgccga ggccacgcgg agtacgatcg agggtacagc ataatctcaa 2880
cttttgttga gccacaattt taatcctaat tggagaaggc caaaggactg tactacttct 2940
gtaggtgtag cagtcgccca gtgggaaagc gccaactagg ttacaattgt ggtggggaca 3000
aattagggga aattaaattg gcttataggg gggatggagc aaaaaaaaaa aaaaaaaaaa 3060
aaaaaaaggg tcggcatggc atctccacct cctcgcggtc cgacctgggc atccgaagga 3120
ggacgcacgt ccactcggat ggctaaggga gagccactgt gccttctagt tgccagccat 3180
ctgttgtttg cccctccccc gtgccttcct tgaccctgga aggtgccact cccactgtcc 3240
tttcctaata aaatgaggaa attgcatcgc attgtctgag taggtgtcat tctattctgg 3300
ggggtggggt ggggcaggac agcaaggggg aggattggga agacaatagc aggcatgctg 3360
gggatgcggt gggctctatg gaagcttctc 3390
<210> 11
<211> 37
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 11
acatggggac taaagataaa aattatagca ttagtct 37
<210> 12
<211> 21
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 12
ctacctaggc tcggtgcaag g 21
<210> 13
<211> 52
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 13
cttgcaccga gcctaggtag cttgcaggga ttatggatcc aatgggtaca tg 52
<210> 14
<211> 37
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 14
ttgctccatc ccccctataa gccaatttaa tttcccc 37
<210> 15
<211> 43
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 15
tagcactcct tgcaccgagc ctaggtagga taaaaccccc tac 43
<210> 16
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 16
ggcaaattta atggcaggac 20
<210> 17
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 17
gtcctgccat taaatttgcc 20
<210> 18
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 18
gttgtgaatc gatttgcaag 20
<210> 19
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 19
cttgcaaatc gattcacaac 20
<210> 20
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 20
cagagtgcat ctattgctgc 20
<210> 21
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 21
gcagcaatag atgcactctg 20
<210> 22
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 22
actgctggaa ttcctcgtgg 20
<210> 23
<211> 20
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 23
ccacgaggaa ttccagcagt 20
<210> 24
<211> 42
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 24
gcacctccat gtacccattg gatccataat ccctgcaagg ag 42
<210> 25
<211> 34
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 25
ggcgtgcact tgacattgat tattgactag ttat 34
<210> 26
<211> 59
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 26
taatttttat ctttagtccc catgtacggt tcactaaacg agctctgctt atatagacc 59
<210> 27
<211> 59
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 27
atagggggga tggagcaaaa aaaaaaaaaa aaaaaaaaaa aaagggtcgg catggcatc 59
<210> 28
<211> 34
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 28
gagaagcttc catagagccc accgcatccc cagc 34
<210> 29
<211> 1080
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 29
ccaagttggt gattacattc ttgctaaaac agatggcagt gacacttata cttacagagg 60
aacatctacc tacaaactcc aaacaggtga tgttctagtc ttaatggcac atgttgttac 120
accgctctca gcaccccctg tgctaacgca gacaacatat gtcagaaaat cacttttacc 180
cgactctgtt ggtgcgtctt attatgtgca acattttaag tcatataatg agatagctat 240
gcagagggtt acaacagtat taggtccgcc aggcacaggt aagtcaacct ttgctattgg 300
tttggctaag tactttccta gtgcacgtat ttgctacact gcgtcttcgc atgcagcaat 360
agatgcactc tgtgaaaaag ctttcaagac aatacctgta ggccaatgca gtcgtatcgt 420
acccacacgt acaactgttg agtgctttca ggagtttgtc gtaaataaca caactgcaca 480
gtatatcttc tcgactatca atgccttacc tgacattaag tgtgacattg tagttgtaga 540
tgaggtttct atgttgacca attatgagct ttcctctgtg aatgctcgtt tggtttacaa 600
tcacattgtg tatgttggtg atccttatca gttaccttca cctagaacta tgcttacgtc 660
tggccagctt tcgccagctg actataacgt agttactgat ataatggtac atgcaggagc 720
ggacgttatg ctcgacatgt gctacagatg cccacgtgaa atcgttgaga cagtgtctaa 780
acttgtctac gataacaaac taaaagcggc gaaaccgaac tcaagacagt gttacaagac 840
cattgtgaac tttggtcctg gagacgttgc tcatgaggga caatctgcct acaacgaagc 900
acagttgcgt ttcgcactcg catttagaca acaaaagcgg tgggataacg tgactttcat 960
atctccatat aatgctatga atgtgaaagc atccttagca ggtttctcta ctcagaccgt 1020
tgactcttct caaggttctg agtatgatta tgttatcttt tgcgtgacca ctgactcagc 1080
Claims (7)
1. A construction method of infectious clone plasmid of porcine delta coronavirus is characterized by comprising the following steps:
(1) extracting RNA of the porcine delta coronavirus and performing reverse transcription to obtain cDNA;
(2) using the cDNA as a template, designing primers to carry out PCR amplification respectively to obtain a 5 'end gene sequence, a 3' end gene sequence and 5 gene fragments of the porcine delta coronavirus, wherein the 5 gene fragments contain a homologous sequence of 20bp, and in addition, a 15121 site C silencing mutation is changed into A, so that a ClaI endonuclease sequence is eliminated and is used as a genetic marker;
(3) taking pBAC-AJ1102 plasmid as a template, designing primers, and respectively carrying out PCR amplification to obtain a CMV promoter and an HDV-BGH gene sequence;
(4) cloning a CMV promoter, a 5 'end gene sequence, a 3' end gene sequence, a poly (A) structure of 27 adenine deoxynucleotides (A), a hepatitis C virus (HDV) ribozyme self-cleavage site and a bovine growth hormone termination sequence (BGH) into a low-copy vector pBeloBAC11 by using an ApaLI and HindIII restriction endonuclease and a multi-step fusion PCR method by using a BAC system to obtain an intermediate vector pBAC-M-PDCoV;
(5) 5 gene segments are subjected to homologous recombination in proportion and are cloned into an intermediate vector pBAC-M-PDCoV in one step to obtain a recombinant plasmid pBAC-CHN-HN-2014;
(6) transforming the recombinant product into DH10B chemically competent cells, screening positive clones by PCR, carrying out amplification culture on positive clones with correct sequencing, and extracting plasmids.
2. The method of claim 1, wherein the method comprises the steps of: the porcine delta coronavirus is CHN-HN-2014 strain.
3. The method for constructing infectious cloned plasmid of porcine delta coronavirus according to claim 1, wherein the 5 'end gene sequence, the 3' end gene sequence and the 5 gene segments have the sequences of:
5' end gene sequence: 1, SEQ ID NO;
3' end gene sequence: 2, SEQ ID NO;
gene fragment A: 3, SEQ ID NO;
gene fragment B: 4, SEQ ID NO;
gene fragment C: 5, SEQ ID NO;
gene fragment D: 6, SEQ ID NO;
gene fragment E: SEQ ID NO 7.
4. The method for constructing infectious cloned plasmid of porcine delta coronavirus according to claim 3, wherein the primers for PCR amplification of 5 'end gene sequence, 3' end gene sequence and 5 gene fragments are respectively:
PDCoV-5’-F:SEQ ID NO:11
PDCoV-5’-R:SEQ ID NO:12
PDCoV-3’-F:SEQ ID NO:13
PDCoV-3’-R:SEQ ID NO:14
A-F:SEQ ID NO:15
A-R:SEQ ID NO:16
B-F:SEQ ID NO:17
B-R:SEQ ID NO:18
C-F:SEQ ID NO:19
C-R:SEQ ID NO:20
D-F:SEQ ID NO:21
D-R:SEQ ID NO:22
E-F:SEQ ID NO:23
E-R:SEQ ID NO:24。
5. the method of claim 1, wherein the method comprises the steps of: the sequence of the CMV promoter is shown as SEQ ID NO. 8, and the sequence of the HDV-BGH gene is shown as SEQ ID NO. 9.
6. The method of claim 5, wherein the method comprises the steps of: the primers for PCR amplification of the CMV promoter and the HDV-BGH gene are respectively as follows:
CMV-F:SEQ ID NO:25
CMV-R:SEQ ID NO:26
HDV-F:SEQ ID NO:27
BGH-R:SEQ ID NO:28。
7. the method of claim 1, wherein the method comprises the steps of: in the step (5), the molar ratio of the 5 gene segments to the intermediate vector pBAC-M-PDCoV is 1:2:2:1:1: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110154305.8A CN112852873B (en) | 2021-02-04 | 2021-02-04 | Construction method of porcine delta coronavirus infectious clone plasmid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110154305.8A CN112852873B (en) | 2021-02-04 | 2021-02-04 | Construction method of porcine delta coronavirus infectious clone plasmid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112852873A true CN112852873A (en) | 2021-05-28 |
CN112852873B CN112852873B (en) | 2023-03-24 |
Family
ID=75986581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110154305.8A Active CN112852873B (en) | 2021-02-04 | 2021-02-04 | Construction method of porcine delta coronavirus infectious clone plasmid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112852873B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113584080A (en) * | 2021-07-09 | 2021-11-02 | 华中农业大学 | Construction and application of Nluc-labeled recombinant porcine delta coronavirus infectious clone plasmid |
CN114657213A (en) * | 2022-05-23 | 2022-06-24 | 华南农业大学 | Porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and construction method and application thereof |
CN117286111A (en) * | 2023-03-13 | 2023-12-26 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | Bovine coronavirus isolate, cell line for stably expressing N protein of bovine coronavirus and application of cell line in construction of reverse genetic operating system |
CN117286162A (en) * | 2023-04-14 | 2023-12-26 | 扬州大学 | Recombinant porcine delta coronavirus infectious clone and construction method and application thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1402780A (en) * | 1999-12-03 | 2003-03-12 | 康斯乔最高科学研究公司 | Infectious clones |
CN104975039A (en) * | 2015-06-24 | 2015-10-14 | 方诩 | Recombinant plasmid and application of recombinant plasmid to degrading cellulose raw material |
CN107190022A (en) * | 2017-06-28 | 2017-09-22 | 浙江大学 | A kind of method of rapid build avian infectious bronchitis virus reverse genetic strain |
CN109136200A (en) * | 2018-09-20 | 2019-01-04 | 中国水产科学研究院黑龙江水产研究所 | A kind of recombination infectious hematopoietic necrosis poison and its construction method and application |
CN110079541A (en) * | 2019-05-05 | 2019-08-02 | 华南农业大学 | A kind of method and its application of building coronavirus infectivity clone |
CN110331171A (en) * | 2019-07-11 | 2019-10-15 | 华中农业大学 | A kind of method of efficient rapid build pig enteric coronavirus virus recombinant virus |
CN110468113A (en) * | 2019-08-07 | 2019-11-19 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | The transmissible gastro-enteritis virus velogen strain of recombinant modified and its application |
CN111499763A (en) * | 2020-03-31 | 2020-08-07 | 江苏省省级机关医院 | Specific fully human chimeric antigen receptor targeting MAGE-A1 and application thereof |
-
2021
- 2021-02-04 CN CN202110154305.8A patent/CN112852873B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1402780A (en) * | 1999-12-03 | 2003-03-12 | 康斯乔最高科学研究公司 | Infectious clones |
CN104975039A (en) * | 2015-06-24 | 2015-10-14 | 方诩 | Recombinant plasmid and application of recombinant plasmid to degrading cellulose raw material |
CN107190022A (en) * | 2017-06-28 | 2017-09-22 | 浙江大学 | A kind of method of rapid build avian infectious bronchitis virus reverse genetic strain |
CN109136200A (en) * | 2018-09-20 | 2019-01-04 | 中国水产科学研究院黑龙江水产研究所 | A kind of recombination infectious hematopoietic necrosis poison and its construction method and application |
CN110079541A (en) * | 2019-05-05 | 2019-08-02 | 华南农业大学 | A kind of method and its application of building coronavirus infectivity clone |
CN110331171A (en) * | 2019-07-11 | 2019-10-15 | 华中农业大学 | A kind of method of efficient rapid build pig enteric coronavirus virus recombinant virus |
CN110468113A (en) * | 2019-08-07 | 2019-11-19 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | The transmissible gastro-enteritis virus velogen strain of recombinant modified and its application |
CN111499763A (en) * | 2020-03-31 | 2020-08-07 | 江苏省省级机关医院 | Specific fully human chimeric antigen receptor targeting MAGE-A1 and application thereof |
Non-Patent Citations (6)
Title |
---|
CHAD R.IRWIN等: "In-Fusion Cloning with Vaccinia Virus DNA Polymerase", 《METHODS IN MOLECULAR BIOLOGY》 * |
DONG N.等: "KT336560.1", 《GENBANK》 * |
FRANDSEN等: "Targeted Gene Replacement in Fugal Pathogens via Agrobacterium tumefaciens-Mediated Transformation", 《METHODS IN MOLECULAR BIOLOGY》 * |
LOUISE E. BIRD等: "pplication of In-Fusion Cloing for the Parallel Construction of E.coli Expression Vectors", 《METHODS IN MOLECULAR BIOLOGY》 * |
SEAN C. SLEIGHT等: "In-Fusion BioBrick assembly and re-engineering", 《NUCLEIC ACIDS RESEARCH》 * |
XINRONG ZHOU等: "A strain of porcine deltacoronavirus: Genomic characterization, pathogenicity and its full-length cDNA infectious clone", 《TRANSBOUNDARY AND EMERGING DISEASE》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113584080A (en) * | 2021-07-09 | 2021-11-02 | 华中农业大学 | Construction and application of Nluc-labeled recombinant porcine delta coronavirus infectious clone plasmid |
CN114657213A (en) * | 2022-05-23 | 2022-06-24 | 华南农业大学 | Porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and construction method and application thereof |
CN114657213B (en) * | 2022-05-23 | 2022-08-02 | 华南农业大学 | Porcine acute diarrhea syndrome coronavirus artificial chromosome recombinant vector and construction method and application thereof |
CN117286111A (en) * | 2023-03-13 | 2023-12-26 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | Bovine coronavirus isolate, cell line for stably expressing N protein of bovine coronavirus and application of cell line in construction of reverse genetic operating system |
CN117286162A (en) * | 2023-04-14 | 2023-12-26 | 扬州大学 | Recombinant porcine delta coronavirus infectious clone and construction method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112852873B (en) | 2023-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112852873B (en) | Construction method of porcine delta coronavirus infectious clone plasmid | |
CN110551695A (en) | African swine fever virus four-gene deletion low virulent strain and application thereof | |
CN111748563A (en) | Construction of African swine fever gene deletion low virulent strain and application of African swine fever gene deletion low virulent strain as vaccine | |
EP3158060B1 (en) | Method for rapid generation of an infectious rna virus | |
CN111662885A (en) | Construction, rescue and application of infectious clone of virulent and attenuated strains of two highly homologous genome porcine reproductive and respiratory syndrome viruses | |
CN114058619A (en) | Construction of RIPLET knockout cell line and application of RIPLET knockout cell line as production cell line of picornaviridae virus vaccine | |
CN114015660A (en) | Construction of ten-gene-deleted attenuated African swine fever virus strain and application of ten-gene-deleted attenuated African swine fever virus strain as vaccine | |
CN110904055B (en) | PRRSV-SP (porcine reproductive and respiratory syndrome virus) recombinant vaccine strain, and preparation method and application thereof | |
CN114134179B (en) | Porcine reproductive and respiratory syndrome chimeric virus expressing G2 type porcine epidemic diarrhea virus S/S1 and application thereof | |
CN115786280A (en) | Recombinant GI type Japanese encephalitis virus stably expressing red fluorescent protein mCherry and construction method and application thereof | |
CN113584080A (en) | Construction and application of Nluc-labeled recombinant porcine delta coronavirus infectious clone plasmid | |
CN115161287B (en) | Recombinant porcine reproductive and respiratory syndrome virus and construction method and application thereof | |
CN110904056B (en) | Infectious bronchitis virus rH120-YZS1 delta 5a and construction method and application thereof | |
CN110331155B (en) | Carrying type 2 BVDV-ErnsConstruction method of genetic high-fertility swine fever attenuated marker vaccine | |
CN114317574B (en) | Marc-145 cell-adaptive type 1 pig breeding and respiratory syndrome virus cultivation and application thereof | |
Wang et al. | Construction of a Triple Gene-Deleted Live Vaccine Candidate against Pseudorabies Virus Using CRISPR/Cas9 and Cre/LoxP System-Based Strategy. | |
CN114480378B (en) | Construction method and application of novel goose parvovirus SD strain full-length infectious clone for causing short beak and dwarfism syndrome of duck | |
CN111849990B (en) | ORF016 gene-deleted goat pox virus strain and preparation method and application thereof | |
CN113969267B (en) | Porcine reproductive and respiratory syndrome mutant virus and construction method and application thereof | |
CN118620850B (en) | Preparation and application of avian infectious bronchitis virus attenuated strain | |
CN111944768B (en) | Heat-resistant foot-and-mouth disease recombinant virus strain and application thereof in preparation of foot-and-mouth disease inactivated vaccine | |
CN114836392B (en) | PRRSV (porcine reproductive and respiratory syndrome virus) weak virus and preparation method and application thereof | |
CN116004551B (en) | Construction and application of porcine reproductive and respiratory syndrome virus live vaccine for regulating MHC-II transactivator CIITA gene | |
CN117025675B (en) | Method for improving exogenous gene expression quantity of Admax recombinant adenovirus packaging system and application | |
CN110305853B (en) | Carrying type 1 BVDV-ErnsConstruction method of genetic high-fertility swine fever attenuated marker vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |